TW387814B - Device for injecting medical product - Google Patents

Device for injecting medical product Download PDF

Info

Publication number
TW387814B
TW387814B TW85100851A TW85100851A TW387814B TW 387814 B TW387814 B TW 387814B TW 85100851 A TW85100851 A TW 85100851A TW 85100851 A TW85100851 A TW 85100851A TW 387814 B TW387814 B TW 387814B
Authority
TW
Taiwan
Prior art keywords
piston
gas spring
plunger
nozzle assembly
chamber
Prior art date
Application number
TW85100851A
Other languages
English (en)
Inventor
Stephen J Lilley
Hugh F Taylor
David R Theobald
Craig J Carlson
David I Rosen
Original Assignee
Medi Ject Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medi Ject Corp filed Critical Medi Ject Corp
Application granted granted Critical
Publication of TW387814B publication Critical patent/TW387814B/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/30Syringes for injection by jet action, without needle, e.g. for use with replaceable ampoules or carpules
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F41WEAPONS
    • F41BWEAPONS FOR PROJECTING MISSILES WITHOUT USE OF EXPLOSIVE OR COMBUSTIBLE PROPELLANT CHARGE; WEAPONS NOT OTHERWISE PROVIDED FOR
    • F41B11/00Compressed-gas guns, e.g. air guns; Steam guns
    • F41B11/60Compressed-gas guns, e.g. air guns; Steam guns characterised by the supply of compressed gas
    • F41B11/64Compressed-gas guns, e.g. air guns; Steam guns characterised by the supply of compressed gas having a piston effecting a compressor stroke during the firing of each shot
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F41WEAPONS
    • F41BWEAPONS FOR PROJECTING MISSILES WITHOUT USE OF EXPLOSIVE OR COMBUSTIBLE PROPELLANT CHARGE; WEAPONS NOT OTHERWISE PROVIDED FOR
    • F41B11/00Compressed-gas guns, e.g. air guns; Steam guns
    • F41B11/60Compressed-gas guns, e.g. air guns; Steam guns characterised by the supply of compressed gas
    • F41B11/64Compressed-gas guns, e.g. air guns; Steam guns characterised by the supply of compressed gas having a piston effecting a compressor stroke during the firing of each shot
    • F41B11/642Compressed-gas guns, e.g. air guns; Steam guns characterised by the supply of compressed gas having a piston effecting a compressor stroke during the firing of each shot the piston being spring operated
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F41WEAPONS
    • F41BWEAPONS FOR PROJECTING MISSILES WITHOUT USE OF EXPLOSIVE OR COMBUSTIBLE PROPELLANT CHARGE; WEAPONS NOT OTHERWISE PROVIDED FOR
    • F41B11/00Compressed-gas guns, e.g. air guns; Steam guns
    • F41B11/60Compressed-gas guns, e.g. air guns; Steam guns characterised by the supply of compressed gas
    • F41B11/64Compressed-gas guns, e.g. air guns; Steam guns characterised by the supply of compressed gas having a piston effecting a compressor stroke during the firing of each shot
    • F41B11/642Compressed-gas guns, e.g. air guns; Steam guns characterised by the supply of compressed gas having a piston effecting a compressor stroke during the firing of each shot the piston being spring operated
    • F41B11/646Arrangements for putting the spring under tension
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F41WEAPONS
    • F41BWEAPONS FOR PROJECTING MISSILES WITHOUT USE OF EXPLOSIVE OR COMBUSTIBLE PROPELLANT CHARGE; WEAPONS NOT OTHERWISE PROVIDED FOR
    • F41B11/00Compressed-gas guns, e.g. air guns; Steam guns
    • F41B11/80Compressed-gas guns, e.g. air guns; Steam guns specially adapted for particular purposes
    • F41B11/81Compressed-gas guns, e.g. air guns; Steam guns specially adapted for particular purposes for ejecting powder, e.g. pepper
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2006Piercing means
    • A61J1/201Piercing means having one piercing end
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/202Separating means
    • A61J1/2044Separating means having slits
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2048Connecting means
    • A61J1/2051Connecting means having tap means, e.g. tap means activated by sliding
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2048Connecting means
    • A61J1/2055Connecting means having gripping means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2096Combination of a vial and a syringe for transferring or mixing their contents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/20Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
    • A61M5/2053Media being expelled from injector by pressurised fluid or vacuum

Landscapes

  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Media Introduction/Drainage Providing Device (AREA)

Description

A7 ___B7_ 五'發明説明ς ) 技術領域 本發明係關於一種用於注射藥物或類似物之無針式注射 系統,特別是指利用一氣簧將藥物排出注射器外之無針式 注射裝置或注射器,本發明之氣簧可用於無針式注射器以 及其他裝置如空氣槍,注射系統亦包含一可棄置之快拆聯 結裝置,以將一藥物供給瓶聯結至無針式注射器或類似 物。 背景 目前已有不同型式之無針式注射裝置揭示,例如登樂之 5,〇62,830號、莫洛等人之4,790,824號、林德梅爾之 4,623,332號、柯罕之4,421,508號、修培之4,089,334號、加 沙威之3,688,765號、莫蘭度之3,115,133號、凡帝堤等人之 2,816,543號及史卡洛之2,754,818號等美國專利,這些注射 器皆可在足夠之壓力下將藥物做良好而高速之噴送,使其 通過表皮而不需要皮下注射針。諸注射器通常具有—含有 内室以留置藥物之喷嘴總成,其設有—細孔可供藥物喷流 利用一接於動力源之柱塞而排出室外,此動力源通常為一 捲繞彈簧,如’830、,543及,818號專利所述者。 無針式注射器可對表皮或皮下區域提供一較無疼痛感且 有效之藥物注射,故其被視為較適於此種用途,例如糖尿 病患者即需每曰使用一或多劑之胰島素,以保持適當之血 糖平衡,若使用注射針,則因針刺本身之令人反感,患者 聽從醫師之療法會進行不力,另一方面,使用無針式注射 器時,由於無針頭而可免於針刺,患者會較樂於配合醫師 •4- 本纸張ΛΑίΪΛ中國8|家標率(CNS ) ( 2ι〇χ297公翁}--- ύ. (請先閱讀背面之注意事項再填寫本頁) 装· 、11 經濟部中央橾準局員工消费合作社印製 A7 B7 五、發明説明(2 ) 之治療。此外,反覆對相同膚面施以打針注射會造成皮膚 或表皮受損’無針注射器亦提供另一優點,其中藥物在皮 下散佈之量係大於利用習知注射針之藥丸注射。 此外,由於AIDS、肝炎及其他濾過性病毒之蔓延,醫療 組織十分重視使用傳統注射針發生之意外針刺機率,以及 有關於針頭棄置之問題,因此,特殊之廢棄容器或類似物 需依規定集收及處理用過之針頭,無針式注射裝置即可免 去舊針頭之相關問題,且較適合使用。 雖然無針式注射器有此優點,但是目前已知之輕便式無 針注射器仍有一些缺失’包括其無法在藥物射出喷嘴總成 期間提供充分之怯定壓力,因此,嘴嘴總成内之藥物在彈 簧力不足時會無法完全注射入目標區内,造成濕式注射, 關於此點’前述之'332專利使用大量之同轴向對準之碟片彈 簧’試圖克服此項缺失,惟,這些碟片彈簧不僅使注射器 變重,且其十分複雜而不必要地輸出一均勻之壓縮負荷D 在解決以碟片彈簧為動力源之相關問題時,以—較簡易且 強力之捲繞彈簧取代碟片彈簧之例子可見於迪克生之 4,722,728號專利,惟,捲繞彈簧具有前述之缺點,即其並 未產生一大致怪定之射壓輸出。 經濟部令央樣隼局貝工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 此外,捲繞彈簧式操作系統會受限於可對一即定尺寸柱 塞施加之最大施力值,通常其需具有一精巧且令用者接受 之裝置,若需用較大之裝置則捲繞彈簧尺寸需因而增加, 有違精巧性之要求;此外,以即定之精巧尺寸而言,其需 較大之施力變化以做多樣化藥物及劑量之注射,習知之裝 -5- 本紙張尺度遴用中國a家標率(CNS ) A4规格(210X297公釐) 經濟部中央棣準局負工消费合作社印袈 A7 B7 五、發明説明(3 ) 置並未能解決此項缺點。 前項之'508號專利中,為了試囷調整施加於一無針式注射 器柱塞4壓力值,其係使用一動力真空壓縮單元做為動力 源,壓力雖可由此一裝置調整’但其可攜帶性及尺寸卻十 分不利,因其需要一分離式之供電器以運作真空壓縮單 元。 此領域中之習知另一種動力源係一氣體軀送器,例如,824 及’765號二專利所示之C〇2卡匣,卡匣之c〇2用於推動柱 塞及將藥物排出噴嘴總成外,惟,c〇2卡匣之缺點在於其 僅產生有限之壓力範圍且壓力輸出對於周界溫度極為敏 感,即C〇2之壓力會隨周界溫度而變動,就此而言,如欲 正確操作此裝置而不受周界溫度影響,則需包含一調壓裝 置,致使裝置更為複雜。 前述之’334號專利中,為了產生所需之壓力以推動柱塞, 其使用一氣體產生之火花荷電器,尤其荷電器可爆炸產生 加壓之氣體以作用於柱塞上,再者,此種裝置亦有其缺 點,第一,爆炸荷電器所生之壓力每次在其爆炸時會產生 不必要之均勻壓力,例如不同之爆炸荷電器產生不同之壓 力程度,即使所用之荷電量相同,但其在不同速率下會有 不同之燃燒。另一缺點在於因為氣體係直接作用於柱塞 上,排出之氣體可能會溢出柱塞之密封外而污染藥物,更 嚴重的是排氣可能注入皮内,尤其在壓力超過操作限度 時。 氣壓式動力源已曾有人嘗試,例如沸格生之2 -6- 本紙張尺度適用中國國家標準(CNS ) ( 210X297公羞) L,——,-----('裝 II (请先閲讀背面之注意事項再填寫本頁)
*1T iw 經濟部中央樣準局貝工消费合作社印製 Α7 Β7 五、發明説明(/ ) 號、小漢林之2,737,946號及洛克哈特之2,322,245、 2,380,534號美國專利所述即為用於驅動一無針式丨主射器之 柱塞’尤其是一由注射器主禮所界定之加壓室可另以手操 作壓縮以儲存能量’以利推動柱塞。惟,其並未設計在注 射期間之恆定壓力下輸送藥物,其缺點即如同捲繞彈簧或 操作裝置者。 吾人實需盡量簡化無針式注射器之構造及使用,並使其 輕便而易於攜帶,此種改良使其用者較願意採用,就此而 言’登樂之4,507,113號及林德梅爾之4,883,483、4,662,878 號美國專利皆說明一種轉接件,可從一藥物供給瓶直接經 由射出孔而注入一喷嘴總成之内室,此不僅在藥物配送後 無藥物殘留注射器内,且亦不需具備如艾里古奇等人之 4,059,107號及富吉之3,908,651號美國專利所示嵌入無針式 注射器内之複雜閥設計或藥物供給裝置。 前述'113號專利之轉接件係使用一需對準及轉動之刃形安 裝件’同樣,·483及·878號專利之轉接件亦具有一具備旋轉 接頭之螺接安裝件。這些轉接件之另一缺點在於其以一銳 利之中空針伸出主體外,若未謹慎處理則易傷及使用者即 扎傷。 吾人有必要利用一安全且簡化構造之可棄置轉接件或聯 結裝置以促進無針式注射器之使用,此裝置可快速拆接於 注射器’申請人即發明出此種聯結裝置。 申請人創造之無針式注射裝置藉由提供對現有之無針注 射器之多項改良而克服上述缺點,此外,申請人發明一種 -7 · 本紙張尺度適用中國國家搮準(CNS > Α4规格(210X297公釐) (請先閲讀背面之注意事項再填寫本頁) 裝. ,•11 5 5 A7 B7 五、發明説明( 軋簧,可用於任意之無針式注射裝置及其他裝置,包括一 投射物發射裝置如空氣槍,就此而言,泰勒等人之 5’193,517、4,771,758及4,709,686號美國專利皆說明一些應用 在氣槍中之習知氣簧例子。 發明概述 本發明係指一種無針式注射系統,其包含一用於注射藥 物<無針式裝置’特別是指可將藥物注入患者體内之可攜 帶單手操作裝置。本發明亦包含一聯結裝置,用於將一藥 物供給瓶聯結至一無針式注射裝置或類似物之噴嘴總成。 本發明另指一種氣簧,其可用於需要動力源之裝置,包括 無針注射器及例如空氣槍之投射物發射裝置。 本發明之無針式注射器包含一喷嘴總成,其具有一小瓶 室可容置藥物及一動力機構或動力裝置,喷嘴總成具有一 細孔可流通於小瓶室,供小瓶室中之藥物進出,喷嘴總成 最好可拆接且在必要時可預先填入藥物,或為可棄置式。 一壓力壁件最好即一柱塞,其可移動地設於容置藥物之 小瓶室内’動力機構包含一氣簧,其結構可選擇地聯結於 壓力壁件,其最好呈不連續狀及自容式,以利更換。氣脊 迅速移動壓力壁件,並以一大致均勻之壓力將藥物排出小 瓶室。 依本發明所示’氣簧包含一氣簧壓力室,係由_管狀套 筒及一對最好為端塞且用於封閉管狀套筒之封閉端所界 定,一活塞穿過端塞並佔用氣簧室之一部份,氣勞室係p 氣體加壓’最好為氮氣。活塞可相對於端塞滑動,但其^ -8 - ^紙辣尺度適用中國蹯家樣準(CNS ) A4規格(210X297公釐) itv n^i HI I . nn n (請先Mit背面之注意事項再填寫本頁)
、1T 經濟部中央揉举局負工消费合作社印裝 * n n 1 ·
經濟部中央橾準局負工消费合作社印«. A7 B7_ 五、發明説明(6 ) 閉該室以保持氣簧室中之壓力,活塞具有一第一活塞部份 及一第二活塞部份’而第—活塞部份大於第二活塞部份, 至少一部份之第二活塞部份在活塞處於中性狀態時係佔有 氣簧室,此時氣簧室可藉由將較大之第一活塞部份移入氣 餐室而進一步磨縮°第一活塞部份之直徑至少為第二活塞 部份者之二倍,但是二者之其他直徑比亦可採用,此依所 需之壓力上异或彈力常數而定,惟,為了保持恆定之彈 力,氣簧室之容積應大於活塞在完全壓縮時所佔之容積, 最好為4 : 1以上。 第二活塞之一部份通過氣簧室,且其自由端聯結或接於 一氣簧聯結機構。動力機構另包含一觸發機構,其在操作 上可結合及脫離於聯結機構’以保持氣簧於其壓縮狀態及 自壓縮狀態釋放氣簧。 在一實例中,喷嘴總成及氣簧係接於一主殼體,主殼體 可由任意耐久材料製成’而可承受應力及應變,而最好為 液晶聚合物。動力機構另包含一接於殼體之作動機構,作 動機構係固定觸發機構且可相對於殼體移動,藉由結合聯 結機構及將作動機構移離套筒,第二活塞部份可拉出氣簧 室外’而使第一活塞部份進入氣簧室,以利進一步壓縮氣 簧室。 另一實例中,氣簧及觸發機構係容置於殼體内,而作動 機構可移動地接於殼體,噴嘴總成係接於作動機構,以利 沿作動機構移動,作動機構利用將第一活塞部份推入氣簧 室而壓縮氣簧’此舉可將氣簧聯結機構移入觸發機構,使 -9- 本紙張尺度適用中國國家標率(CNS ) A4规格(210X297公釐) (請先聞讀背面之注意事項再填寫本頁) 裝. 訂 Α7 Β7 經濟部中央揉準局負工消费合作社印製 五 '發明説明(7 ) 氣簧保持在進一步壓縮狀態。 第一活塞部份之自由端在操作上係接於柱塞,最好能以 一空轉連接機構連接於柱塞及第一活塞部份之間,以利於 柱塞及活塞之間產生一預定之自由空隙,空轉連接機構因 而可令活塞在將柱塞推入小瓶室之前先移動一預定距離, 例如空轉連接機構可包含一管狀撞鎚,撞鎚具有一由柱塞 之連接轴佔據之縱向長孔,供抽做相對之滑移。轴可具有 一預定長度’以利於柱塞一端及撞鎚一端之間產生一預定 空隙’撞鎚之末端可在空隙封閉後即結合於柱塞。 另者’空轉連接機構可供活塞或所用撞鎚及柱塞之間做 可拆接式之銜接,而柱塞及第一活塞部份二者之其中一端 具有一快拆彈性扣接接頭,且柱塞及第一活塞部份二者之 另端則具有一相配合之結合裝置,例如一擴大端或頭部, 或一具有擴大頭部及預定寬度環槽形部份之槽形頭部;在 藥物送入該室期間’本發明之空轉連接機構使柱塞斷接於 氣體活塞所需之力大於將壓力壁件移離設端壁之力。 空轉連接機構最好能使柱塞無法脫離氣體活塞或所使用 之撞鎚’而不必先露出柱塞,即移除喷嘴總成,就此而 各,接頭具有至少一扣接叉形件,而以四具為佳,各由彈 性材料製成,可在接於擴大頭部時膨脹且在叉形件末端接 於擴大頭部時回復其原有形狀,尤其一短片自各又形件伸 出而結合擴大頭部之肩部,以利保持結合,整個柱塞包括 叉形件皆拘限於小瓶室内。雖然叉形件可在小瓶室内滑 動’但是室之内壁可限制叉形件於橫向向外移’以利於使-ιο ί (請先閲讀背面之注意事項再填寫本頁) ί ·* 本紙張尺度適用中國困家樣準(CNS ) Α4規格(210χ297公瘦) 經濟部中央橾準局員工消费合作杜印製 A7 __— B7 五、發明説明() v8 ' 用期間保持活塞結合於柱塞,柱塞欲脫離叉形件時可先將 喷嘴總成旋出注射器以露出叉形件,由於叉形件不再由小 瓶室壁拘限,叉形件即可向外膨脹,並於向外拉時釋放擴 大頭部。 本發明之另一特性包含一無針式注射裝置,其中殼體可 全部或局部由耐久之塑膠合成物製成,例如前述之液晶聚 合物,可購自VECTRA品牌,此種合成物可減輕重量且有 助於省略金屬殼體組裝及操作時之潤滑問題。 本發明之又一特性包含一喷嘴總成,可由承受高壓及應 力之強化材料製成,例如r穩定耐高衝擊聚碳酸酯、聚丙 缔及其任何衍生物’或可在使用期間承受壓力及應力之任 意藥用材料或合成物,噴嘴及柱塞可用相同材料,包括不 錄鋼’尤其噴嘴總成包含一至中空圓筒體,其一端呈圓雖 狀而另端呈開口狀,主體之内壁構成一圓筒形之小瓶室。 喷嘴總成包含梯形外螺紋或任意習知之接合件,以利迅速 拆接於注射器,槽或任意接附裝置如蓋接表面可結合於聯 結裝置之快拆件者可設於喷嘴總成之外侧,以利接上—藥 物填注裝置。 —一柱塞具有一相符於圓錐形之壓力壁,其係定位於小瓶 室内,相對於壓力壁之柱塞末端則具有一接頭,可如上述 拆接於一活塞或撞鎚或類似物之一端。一止動件在必要時 可設於噴嘴總成之末端,以利於喷嘴總成脫離注射器期間 將柱塞固定於其内部,另者,止動件在使用上述之快拆二 時則可省略不用。 -11 - ( CNS ) A4«^ ( 210X297^ ) (請先閱讀背面之注意事項再填寫本頁) 装· 經濟部中央樣準局負工消费合作社印氧 A7 _______________________B7 五、發明説明(9 ) •本發明…特性包含一聯結裝置,用於將-藥物供給 瓶聯結至針式汪射裝置或類似物之嘴嘴總成,聯結装 置包含一中空主體,主禮具有第—端及相對於第一端之第 -端’王體最好呈圓筒%,但亦可為其他形狀。一分隔壁 具有-第-侧及-相對之第二侧,其係設於第一、二端: 間’第-侧較接近第-端而第二侧較接近第二端,分隔壁 另具有一貫穿孔;—中空針自壁之第-侧伸向第一端,其 自由端終止於主體内,故其並未伸出第一端外,針之位置 可供流體流通至貫穿孔。 一藥物供給瓶接頭設於第—端上,用於連接一藥物供给 瓶,以容許該㈣入但τ防止其移出,—㈣接頭設於第 二端上,其具有至少一快拆件以抓持喷嘴總成之一部份, 其連接方式係利用將接頭推向喷嘴總成而成,而斷接方式 係利用施加一足夠之拉力及/或扭轉力。瓶子接於噴嘴接頭 時針即刺過一瓶密封件,供流體流過貫穿孔。聯結裝置藉 由推向喷嘴總成而接至無針式注射器,並藉由拉動及/或扭 轉而脫離注射器,當該瓶推向針時,針刺穿密封件並供 流體自該瓶流向設於壁上之貫穿孔。 聯結裝置另包含一可拉伸之薄膜密封件,係鄰接於分隔 壁之第二侧,密封件可具有一零直徑之開口,係對齊於貫 穿孔’但最好具有一開孔,零直徑開口封閉該貫穿孔,直 到藉由密封件拉伸開啟為止^密封件鄰接於分隔壁之第二 側,以利於噴嘴總成及貫穿孔之間產生水密,一圏環最好 鄰設於密封件,環之結構係配合於喷嘴之形狀,以利喷嘴 -12- 本紙張尺度埴用中困國家揉準(CNS ) Α4Λ格(210X297公釐) (請先聞讀背面之注意事項再填寫本頁) 裝· 經濟部中央標隼局負工消费合作杜印袈 A7 B7 五、發明説明() 10 ' 總成準確對齊於聯結裝置,一防護蓋設於第二端,其可結 合於圈環及快拆件,以利保護及封閉第二端,蓋予具有酉°己 合之表面可結合於快拆件。 瓶子接頭包含至少一伸向壁面之撓性齒,其中齒之一端 結合於供給瓶之一部份,供給瓶具有裝置可結合於齒,以 防止其脫離於聯結裝置。接頭最好包含一對撓性之相對立 齒,係自主體之第一端伸向分隔壁之第一侧’相對立之齒 在朝向分隔壁之方向逐漸互相靠近,二者之自由端皆可結 合於供給瓶之一部份,以防止瓶子脫離。 噴嘴接頭最好具有多枚快拆件,各大致延伸平行於主 體’快拆件具有彈性’可在喷嘴總成或蓋子插入期間在徑 向互相膨脹分離,而在完全插入時回復原狀,各快拆件具 有一徑向向内之突伸部份,係結合於喷嘴總成以利固接 之。 本發明之另一特性在包含一上述之階級狀氣簧,可輸出 恒疋之力’其具有一在套筒之—端呈抽向向外延伸之第 一活塞部份及一在套筒另端以相反方向在徑向向外延伸之 第二部份,第一、二活塞部份之其中一者包含一活塞抓持 裝置’而最好為一設於活塞部份周侧之圓形槽或槽道或類 似物’圓形槽最好設於接近第二活塞部份之自由端。階級 狀氣簧另包含一裝置,可防止套筒移動及壓縮活塞,止動 及壓縮裝置可為一無針式注射器或一投射物發射裝置,其 另包含一裝置,用於拉動第二活塞部份或推動第一活塞部 份。 -13- 本纸張尺度適用中國國家標準(CNS ) A4规格(210X297公釐) l·--·------装-- C (讀先閲讀背面之注意事項再填寫本頁) 訂 經濟部中央揉準局貝工消费合作社印«. A7 _______B7五、發明説明(^ ) 11 本發明之再一特性係包含一利用壓縮空氣發射出一投射 物之投射物發射裝置,發射裝置包含一外中空虹鍵缸體 具有一侧壁及一備有排氣孔之封閉端壁,一備有中心孔之 圓筒接於缸體且中心孔連通於排氣孔,一備有封閉辟件之 擊發活塞設於中空缸體内,可於其内移動,封閉端爲、封 閉壁件及侧壁界定一氣簧室。一階級狀氣簧連接於擊發活 塞,可迅速將擊發活塞移向封閉端壁,以利壓縮擊發室内 之空氣,發射裝置包含一將擊發活塞推離封閉端壁之機構 及一保持擊發活塞遠離於封閉端壁之觸發機構。 依本發明所示,第二活塞部份係接於擊發活塞,第—舌 塞部份在套筒之一端呈袖向向外延伸,而第二活塞部份在 套筒另端以相反方向呈轴向向外延伸,一觸發結合刻槽投 於第二活塞部份上,以利結合觸發機構及保持活塞於一動 力壓縮狀態,第一活塞部份之一端係接於擊發活塞。 圖式簡單說明 本發明之上述及其他特徵、特性及優點可由以下說明、 申請範圍及相關圖式獲得瞭解,其中: 圖1係本發明無針式注射器之截面圖U,且作動機構在密封 狀態而氣簧在其中性狀態I 圖2係圖1所示無針式注射器之截面圖,且作動機構在伸 出狀態而氣黃在動力狀態。 圖3係圖2所示無針式注射器之截面圖,但是氣簧在其中 性狀態。 ' 圖4係本發明無針式注射器之另一實例截面圖,且作動機 -14-
(請先Μ讀背面之注意事項再填寫本頁) Γν 装. ,·ιτ 經濟部中央標準局員工消费合作杜印装 A7 B7 五、發明説明(12) 構在伸出狀態而氣簧在中性狀態。 圖5類似於圖4之截面圖,且作動機構在密封狀態而氣黄 在動力狀態。 圖6類似於圖5之截面圖,但是作動機構在開啟狀態而氣 簧在動力狀態以備擊發。 圓7係本發明動力機構之放大截面囷。 圖8、9說明活塞用於本發明無針式注射器及氣槍之另— '實例。 圖10顯示氣簧注射器相對於捲繞彈簧注射器之壓力對時 間測量值之代表性數據。 圖11係一示意圖’揭示氣簧.注射器相對於捲繞彈黃注射 器之壓力-時間曲線。 圖12係本發明喷嘴總成之另一實例截面圖。 圖12A說明一柱塞具有一快速接頭,以拆接於本發明氣黃 内之活塞一端’且其一部份係沿斷面線12A-12A說明於圖 12C。 圖12B係沿圖12A之線12B-12B所取之截面圏。 圖12C係圖12A所示柱塞之端視圖。 圖12D係一自氣簧伸出之活塞之一部份,活塞具有_擴大 端。 圖13係本發明噴嘴總成之又一實例截面圖。 -圖14係本發明聯結裝置之立體分解圖。 圖1.5係圖14所示聯結裝置之端視圖。 圖16係圖14所示聯結裝置之另一端視圖。 -15- 本紙張尺度遑用中國國家橾準(CNS >八4规格(210X297公釐) {請先W讀背面之注意事項再填寫本頁) 裝· 訂 A7 B7 經濟部中央棣準局員工消費合作社印» 五、發明説明(13 ) 圖16A係圖14所示聯結装置之另一實例。 圖17係圖14所示聯結装置聯結於一藥物供給瓶及一無針 式注射器之截面囷。 圖18係一氣槍之截面圖,且擊發機構已在備便擊發狀態。 囷19類似於圖18之截面圖,且擊發機構在不擊發狀態。 圖2 0係聯結裝置封環之截面圖,此封環用以接納注射器 喷嘴或防護蓋頂端尖部。 囷2 1係防護蓋之侧視囷,其說明了防護盖澳聯結裝置封 環之配合關係。 較佳實例說明 為了方便起見’圏示實例之本發明相同或等效元件係以 相同編號表示,此外’以下之說明中,任何有關方向或方 位之參考係為了方便說明,不應據以限制本發明之範疇, 圖1 -19即說明本發明之不同實例。 如圖1-6所示,本發明之無針注射系統10包含一噴嘴總成 20、一迫使藥物離開喷嘴總成之動力源或機構4〇及作動並 觸發動力機構40之一作動機構90、90A與一觸發機構100, 這組件在操作時係容置於一殼體200、200A内。 嘴嘴總成20包含一設有一細孔24之嘴嘴件22,細孔直徑 最好約0.07至0.4mm,理想的是0.165mm(0.0065H·)或 可在預定壓力範圍下及注射深度下產生均勻喷流之其他適 當直徑,若需要極均句之喷流時,細孔可由人造寶石製 成’例如· 7 2 8號專利所述之人造紅寶石或藍寶石,應注意 的是細孔係指任意型式之開孔,其包括直式、漸縮式、漸 擴張式 '先漸縮再漸擴張式等。噴嘴總成20可螺接於殼體 -16- (請先閲婧背面之注意Ϋ項存填寫本頁) Γ 裝· 訂 本紙張尺度適用中國國家標準(CNS ) A4规格(210X297公釐) A7 B7 五、發明説明() 14 ' 200或作動機構90A,使其如圖1〇、η所示般可穩定地拆 接’另者,其他習知用於裝接二組件之結構亦可使用,以 利噴嘴總成20拆接於殼體200,依此,無針注射器1 0可配合 不同之噴嘴總成2〇〇反覆使用,而喷嘴總成容裝不同之藥 物’以供不同劑量之不同藥物一併或各別注射,例如噴嘴 總成2 0可預先填充藥物直使用後即棄置之。此外,本發明 之藥物填充裝置如聯結裝置12〇以及·113號專利所述之轉 接件或其他聯結裝置皆可用於將藥物填入小瓶内,·113號 案之内文可供本發明參考。 經濟部中央標準局員工消费合作社印製 (請先閲讀背面之注意事項再填寫本頁) 囷1-6及圖12所示之喷嘴總成20、2〇Α包含一圓筒形小瓶 室26 ’其末端係一正圓錐件28,圖13所示之噴嘴總成2〇8亦 包含一圓筒形小瓶室26,惟其末端係一凸錐件28,,即其壁 面以一凸形曲率呈收縮狀。一柱塞3〇具有一配合圓錐件 28、28·輪廓之壓力壁,其可於小瓶室26内定位及滑移,柱 塞30、30Α、30Β可包含一密封裝置如〇形環或類似物(囷中 未示)且設於外環緣處,以利密封柱塞本身,如,83〇號專利 所述,其内文可供此處參考。柱塞亦可包含相間隔之密封 裝置,以提供較佳之封閉,所示之實例中,柱塞3〇係接於 一與動力機構40相接之揸鎚32 ,另者,撞鎚32在必要時可 固設一動力機構。在一實例中,柱塞包含一備有球形端ha 之連接軸31,撞鎚32接於或固設有一慣性重物%,且由此 接於或固設於氣簧50之活塞58,慣性重物可拆接於活塞及 撞鎚,使重物可適用於不同之注射型式,例如針對藥物之 黏度時,初期之壓力即需依氣簧5〇強度及注射之貫穿深度 -17- 本纸張尺度遄用中國國家揉準(CNS ) A4規格(21〇χ297公着> 經濟部中央樣準局貝工消费合作社印輦 發明説明( 1〇 等而建立,活塞58必要時亦可直接接於柱塞。 右噴嘴總成及柱塞不做棄置,則其可由耐久性之惰性材 料製成,例如不銹鋼,囷12、13特別說明可棄置喷嘴總成 20A、20B之不同實例,其柱塞即由可耐高壓及應力之強力 材料製成,例如r穩定耐衝擊聚碳酸酯、聚丙烯及其衍生 物等,或任意之抗藥物材料,包括玻璃或其組合物,可相 容於藥物及可承受注射器施加之壓力及應力。喷嘴總成 20A、20B最好包含一習知之梯形螺紋25,以利迅速卸除或 連接至殼禮220或作動機構90A,槽27或任何接合裝置可設 於噴嘴總成20A、20B之外侧周固,以利接合例如本發明之 聯結裝置20或如113號專利所示之轉接件。 柱塞30A、30B需與可棄置之喷嘴總成2〇a、20B —併棄 置,就此而言’一止動件29可如圖1〇、11所示般設於噴嘴 總成20A、20B之末端内,以於喷嘴總成斷接於殼體2〇〇、 200A或作動機構90A時可留置其内之柱塞,例如止動件可 結合於叉形件30b之末端’惟,止動件可令撞鎚32或第一活 塞部份58a移至小瓶室26内。此種嘴嘴總成中,任意習知之 快拆裝置皆可使用,以利於使用期間藉由喷嘴總成旋離注 射器及/或施加一大於移動柱塞所需之力拉動噴嘴總成而斷 接,使柱塞可藉由輕易之手部動作而僅脫離於活塞。 另者,'830號專利說明此一可棄置單元,其内文在此可供 參考,請參閱圖12A-12C,柱塞30C大致相似於柱塞30、 30A、30B,不同的是其設有一彈性扣接頭30a,可直接拆接 於第一活塞部份58a之末端’接頭30a具有至少一叉形件3〇b -18- 本紙張尺度適用中國國家標率(CNS ) 规格(2丨0X297公釐) n I n Γ— I I I n t (請先閲讀背面之注意事項再填寫本頁) 訂 經濟部中央樣準局負工消费合作社印製 A7 ____B7_ 五、發明説明(16 ) 而最好有四件,各叉形件大致延伸平行於主體部份3〇c,各 叉形件30b之自由端設有橫伸段或短片3〇d,係在徑向朝其 中心袖線延# _。 圖12D所示之第一活塞部份58a具有一擴大之自由端58c, 可結合於叉形件以提供自由移行或空轉所需之長度,另, 第一活塞部份亦具有一相鄰於一擴大頭之預度寬度環形通 道’如·830號美國專利所示。叉形件3〇b可由彈性材料製 成,其係先接於擴大之自由端或頭58c,可在橫向向外膨 脹’以容許自由端通過短片3〇d,且當擴大端58c通過短片 時可如圖12A所示般回到其原位。擴大頭之厚度或深度d係 小於一端壁30e及短片間所設之寬度w,以利用W-D界定出 一空隙,空隙以至少3.5mm為佳。擴大端58之大小適可在空 隙内相對於柱塞30c自由移動,但是在使用時可防止自柱塞 脫離’尤其短片30d結合於活塞58之肩部58d,且包含叉形 件之整個柱塞係拘限於小瓶室内,雖然叉形件可在小瓶室 内滑移’室之内壁可拘限又形件不至於在橫向向外移動, 因而在使用期間保持活塞結合於柱塞。柱塞30c利用先將噴 嘴總成從離注射器而自擴大端5 8c分離,以露出又形件,由 於叉形件不再由小瓶室壁拘限,其即可橫向向外膨脹,且 在擴大端拉出時將之釋放。若使用柱塞30c時,喷嘴總成 20、20A之小瓶室26内不應有止動件29或類似物,以利柱塞 插入及移出。 主體部3 0c之端壁3 0f及壓力臂件之端壁30g間所形成之空 間可配合一密封裝置使用,例如·830號美國專利之Ο形環。 -19- 本紙張尺度適用中國國家橾準(CNS ) Α4规格(210X297公簸) t--„-----茉II (請先閲讀背面之注意事項再填寫本頁) 訂 經濟部中央樣準局貝工消费合作社印製 A7 ___B7_ 五、發明説明(17 ) 動力機構40包含一用於驅送柱塞30之氣簧50,使其前壁 將藥物排出喷嘴總成之小瓶室26,氣簧50大致同直線於且 相隔於喷嘴總成20,如囷7所示,氣簧單元50包含一具有兩 開口端之套筒52’最好呈圓筒形以配合於注射器之殼體 200、200A形狀。套筒52可在殼體内侧所形成之圓筒形凹部 210内固定或移位’其二開口係利用二端塞54、56封閉,各 端塞具有一中心孔’係對於套筒52之縱軸線,端塞54、56 固定而不致相對於套筒52通過一般之固定裝置。圖式之實 例中’端塞呈圓筒狀,係對應於套筒52之筒形内緣,端緣 定位於套筒52内且鄰近於其開口端,套筒52之二開口端朝 其軸線方向而呈敵褶狀,如圖7所示,以利分別形成圓形之 止動緣55、57,諸止動緣可防止端塞相對於套筒52而互相 遠離。此外,鄰靠滾子158、59可鄰設於端塞之内侧,例如 利用在徑向使套筒52產生皺梢’以防止端塞互相靠近,止 動緣55、57及鄰靠滾子58、59防止端塞在軸向相對於套筒 52移動,可瞭解的是其他止動或固定裝置亦可用於使端塞 54'56定位,例如螺絲、銷、黏膠等。 一階級狀活塞58係相對於套筒及端塞而在相同軸向定 位’使活塞可相對於端塞滑動,階級狀活塞58具有一直徑 為D1之第一部份58a及一直徑為之第二部份58b,如圖7 所示’在較佳實例中,直徑D1至少為二倍於D2,就此而 言’端塞54中之孔需較大,以配合容置第一活塞部份58a。 由套筒52及端塞54、56所界定之氣簧室51最好係以氮或 其他較大分子量之惰性氣體加壓’使用較大分子量之氣體 -20- 本紙張认朝巾邮家料L ( CNS ) A421QX297公瘇) '·I -— - sis- IJ\ I — 1= - - ! 1^1 I. ~ Is— ..... - - I ' ·· (請先閲讀背面之注意事項再填窝本頁) A7 B7 經濟部中央橾準局貝工消费合作社印裝 五、發明説明(18 ) 可減少乳趙溢出’此需端塞相對於套筒5 2及階級狀活塞5 8 封閉。.就此而έ ’欲將端塞54、56封閉於套筒5 2,則各端 塞可備有一第一密封件’例如〇形環62、63,係定位於端塞 54、56外緣上之一槽周侧,應瞭解的是〇形環之直徑最好略 大於端塞上所設各槽之深度,使〇形環壓緊密封於套筒52之 内周緣。欲以氣簧室51相對於活塞部份58a密封時,一第二 密封件64包含一以軟彈性材料製成之碟片64a及一較硬華司 64b,密封件64係在同軸向鄰近於端塞64之内表面,鄰靠滚 子1 58相鄰於第二密封件,以令第二密封件定位。同樣,一 第三密封件66包含一由軟彈性材料製成之碟片66a及一較硬 之固定件66b,其係在同一直線上鄰設於端塞56内所形成之 圓筒形凹部内’固定件66b可使碟片66a無法移動,除了固 定件以外,一類似於華司64b之華司亦可用於使碟片66a無 法移動,另者’任意習知之密封機構皆可使用,其係屬習 知技術之範轉。 一較高壓力之氣簧需要密封件以防止氣體溢出活塞58, 此需要一緊密之接合,以利產生機械式摩擦,藉此減緩活 塞之初期加速度。由於階級狀活塞58需能相對於第二密封 件64、66滑動,因此密封件不應太緊而造成活塞58無法移 動,相較於捲繞式彈簧,氣簧可因此一靜摩擦而有較缓慢 之初期加速度。為了補償此現象,本發明在撞鎚32或活塞 58a及柱塞30之間設有一空轉連接機構,如圖2、6所示,最 好以至少3.5mm之小空陈34設於柱塞30之一端及撞鎚32—端 或第一活塞部份58a之間,而此時活塞係拉離套筒且呈準備 -21 - (請先閲讀背面之注意事項再填寫本頁) [—„------r'-等 訂 線 本紙張尺度適用中國國家標準(CNS ) A4规格(210X297公釐) 經濟部中央棣準局貝工消費合作杜印«. A7 _____B7 _ 五、發明説明(19 ) . 擊發結構,空轉連接件之此項自由空隙移動可利用延遲撞 鎚32或第一活塞部份58a對柱塞30之結合而補償初期較慢之 反應’活塞並不作動,直到其移過空味34之距離,在此點 處撞鎚3 2及/或活塞58已加速或接近至其最大值。據此,當 撞鎚接觸到柱塞時,其已建立足夠之動量可產生刺穿皮膚 所需之初期壓力’依本發明所示,空陈34可調整以改變初 期撞擊在柱塞上之衝力,而產生所需之最高壓力,文後將 做詳述’最高屢·力係取決於藥物黏度、注射貫穿深度及可 影響初期注射壓力輸出之其他變數。 具有一觸發結合刻槽72之觸發延伸段或氣簧聯結機構70 係利用一螺接方式而接於第二部份58b之末端,第一活塞部 份58a之末端則接於慣性重物36,惟若第一活塞部份之重量 足以產生所需之初期動量,即可產生將藥物貫穿至注射深 度之初期壓力建立水準(如概示於圖11之2處及圖J 〇之代表 性數據),則慣性重物即可省略。 如前所述,氣簧室51係以選定度做較高之加壓,氣簧室 中之壓力反比於容積,亦即若氣簧室之容積減小,則壓力 會因谷積減少而成比例地增加’反之亦然。據此,當活塞. 58相對於套筒52而在R方向拉或推動時,直徑大於活塞部 58b者之活塞58a將佔去氣簧室51内之空間,因而減少其禮 積’造成氣簧室51内之壓力上昇。若活塞釋放,其在該方 向加速將減少氣簧室内之壓力,因此,施加於柱塞3〇之力 大致相等於壓力增加所生之力減去因摩擦及熱造成之損 失。 -22- 本紙張尺度適用中國國家標準(CNS ) M規格(2丨0x297公釐) (請先閲讀背面之注意事項再填寫本頁)
-、1T 破 經濟部中央橾準局貝工消费合作社印装 A7 B7 五 '發明説明(2()) 活塞部份58a、58b之間之連接部份58c可為圖7所示之階級 狀,或可為囷8之人字形或圖9之弧形,諸結構中之差異可 忽略不計,因為諸實例間之容積差較小。 圖1-3之實例中,動力裝置作動機構90包含—觸發總成1〇〇 及作動裝置,可沿方向L、R移動觸發延伸段70,此作動機 構90至管狀,且在其旋繞之套筒部份92上設有圓筒形之内 螺紋,可在相同軸向螺接於殼體2〇〇上所設之相對應外螺纹 部份220,尤其螺紋部份220係沿其縱向長度設於其外緣, 旋繞之套筒部份92則沿其一部份縱向長度之内周緣上設有 配合之螺紋94、藉由相對於殼體而以某一方向旋轉旋繞之 套筒部份92’觸發總成及套筒52間之距離可較大,且藉由 在另一方向之旋轉,該距離可較小》 如圖1-3所示,觸發總成1〇〇包含一固接於作動機構9〇之閂 殼體套筒102,閂殼髏套筒102具有一貫穿孔,可供觸發延 伸段70通過,套筒1〇2另具有多數之侧壁孔104,可供圈珠 或滾珠軸承106通過》—管形知1〇8具有一開口端及一封閉 端,其可與套筒1 02做伸縮式定位,知1〇8在其内壁1〇9上設 有一環側或環形槽110,可在觸發機構100位於圖3所示之擊 發位置時(即未結合於觸發延伸段70),可供部份圓珠1〇6結 合於槽110,圓珠106依此定位,使其等高於套筒1〇2之内侧 壁表面103 ’如圖3,可供觸發延伸段70通過套筒102。一閃 珠固定杯112係伸縮地定位於紐1〇8内,如圖3,一壓縮彈黃 114設於杯112及紐1〇8之間’如圖1-3所示’可令鈕108及杯 112在轴向互相遠離。 -23- 本紙張尺度遴用中國國家標率(CNS ) A4规格(210X297公釐) (請先M讀背面之注意事項再填寫本頁) .> 1^1 I I IJ ; --- I HI in — » I : In 11>· HI ^^1 n 1 HI ^11 ϋ In 經濟部中央樣準局貝工消费合作杜印«. A7 B7 五、發明説明() 21 殼體200、200A及作動機構90、9〇A可由任意之耐久材料 製成,包括不銹鋼、塑膠及任意合成材科,如塑料或合成 材,可具有或不具有添加物如結合劑、填充劑、纖維、碳 及類似物等,此屬習知技術。注射器之重量可利用較輕之 塑材而減少,使裝置較易使用,因為較輕之裝置較易操 作,且可供人們在曰常旅行時攜帶此注射器,供任何需要 — >王射器之人們方便使用《在較佳實例中,塑膠合成物係 液晶聚合物’可得自Hoechst Celanese公司之VECTRA品牌 物,尤其是VECTRA A430及A435,這些合成物對重量比提 供一高強度及其他優點,即其在注模及抽拉成型設備中較 方便處理;此外,這些合成物包括PTFE碳氟或氟聚合物, 可增進潤滑性而少用潤滑劑,因為後者係利用金屬結構组 裝及/或操作。 圖1-3之無針注射器操作中,作動機構9〇之套筒部份92係 相對於殼體200轉動,而自圖3之狀態變為圖1之封閉狀態, 使觸發延伸段結合於圓珠106,尤其當觸發機構移向觸發延 伸段70時’其先將閂固定杯U2向外推,使圓珠結合於觸發 延伸段70上所設之觸發結合刻槽72,如圖1、2所示。由於 紐係自由向外移,彈簧114因而將4ft向外錐.,圓珠106鎖定 於刻槽72及紐内侧壁109之間,如圖1、2所示,而將活塞鎖 定於觸發件,關於此點,觸發延伸段70鎖定於作動機構, 使其在其他方向(R)之旋轉移位可令活塞58以相同方向r移 動’而進一步壓·縮氣簧室51,當活塞在方向R移動時,柱塞 同時將藥物抽入小瓶室26(參閱文後有關之聯結裝置12〇 , -24- 本紙張尺度適用中國國家揉率(CNS ) A4规格(210X297公釐) !4·ιιι4^ιι!ιιιι»ιιι^ιι4χ1 I HI c (請先閲讀背面之注意事項再填寫本頁) 訂 線 A7 __B7 五、發明説明(22 ) 其將一藥物供給瓶聯結至無針注射器之喷嘴總成)。欲將積 存於小瓶室内之空氣排出時,注射器可直立且先將一小劑 量之藥物抽入室26内’隨後仍保持直立,藥物完全射出室 26外且進入小瓶内,或接頭斷接而將藥物射出一分離容器 外以利棄置,此依用途或任何之藥物限制而定。室26中之 空氣排入小瓶内或大氣中,然後將所需之藥物劑量抽入室 26,内而無空氣積存於室中此時空隙34可依需求而漸窄, 藉旋轉套筒部份92於適當位置而不必移動柱塞,應注意的 是柱塞不可移動,直到空隙先封閉或完全在其最大值,注 射器即準備擊發。當鈕108向内壓時(朝方向L),槽11〇位於 圓珠上,釋放觸發延伸段72’使活塞在該方向加速,而將 藥物排出小瓶室26外’圖3揭示注射器在其擊發後之狀態。 圖4-6所示之實例係以類似於圖1 -3之方式操作,惟,當活 塞58拉動而供給圖1-3實例中之活塞動力時,圖4_6實例中之 活塞則為推動,喷嘴總成20接於圖1-3實例中之殼體2〇〇 時’喷嘴總成20則接於圖4-6實例中之作動機構90A。 經濟部中央棣準局Λ工消费合作社印簟 L---r-----"ο 裝-- (請先W讀背面之注意事項再填寫本頁) 尤其如圖4-6所示之實例,動力裝置作動機構90A係螺接 於固定氣簧套筒52之殼體200A,觸發總成100接於或容置於 殼體200A内,但是不可相對於殼體移動,如圖ι·3之實例所 示。再者,作動機構90A呈管狀,且在其旋繞套筒部份92A 上設有圓筒形之内螺紋,用於在相同軸向螺接於殼體200A 上所設之相對應外螺紋部份220A,尤其螺紋部份220A係沿 其縱向長度而設於其外緣。旋繞套筒部份92A在沿其一部份 縱向長度之内周緣上設有相對應之螺旋94A,藉由依某一方 -25- 本紙張/iJt逋用中國國家標率(CNS ) A4#t«· ( 210X297公釐} A7 B7__ 五、發明説明ς,) 向相對於殼體200Α轉動旋繞套筒部份92Α,活塞58可推入 觸發總成内’而藉由依另一方向之轉動,嘴嘴總成可移離 活塞。 圖4-6所示之無針注射器操作中,套筒部份92Α先相對於 殼體200Α而從囷4之狀態轉向觸發總成1〇〇,致使柱塞3〇抵 靠於喷嘴總成小瓶室26之圓錐件28,並將第一活塞部份58a 推入氣簧室51内及將第二活塞部份移向觸發總成,直到刻 槽72結合於圓珠1〇6而將氣簧鎖定於囷5所示之完全待擊發 狀態。 目前套筒部份92A係以另一方向旋轉,可將藥物抽入小瓶 室26内及將噴嘴總成抽離柱塞,如圖6所示,再者,為了排 出小瓶室内積存之空氣,注射器可保持直立且藉由依據將 柱塞移離細孔之方向轉動套筒部份,而先將一小劑量之藥 物抽入室26内,使小瓶室中產生真空而將藥物填入小瓶室 内,然後仍保持在直立狀態,藥物完全射出室26外且進入 小瓶内’或接頭可斷接而將藥物注入一分離之容器内以利 棄置’此依用途或任意之藥物限制而定,利用使柱塞移向 細孔之方向轉動套筒部份92A,任何容藏於室26内之空氣得 以排入小瓶内或大氣’然後將所需之藥物劑量抽入室26内 而無空氣積留於室内=此時空隙34可依需求而變窄’而不 必利用在適當方向轉動套筒部份92A以移動柱塞,當鈕1〇8 向内壓時’槽110位於圓珠上,釋放觸發延伸段72,使活塞 在該方向加速,而將藥物排出小瓶室26外,圈4揭示活塞釋 放或擊發後之狀態。 -26- 本紙張尺度遴用中國國家標率(CNS > Α4洗格(210X29*7公釐} rl· — ·------裝 II (請先閲讀背面之注意事項再填寫本頁) 訂 ί" 蛵濟部中央橾準局貝工消费合作社印氧 經濟部中央樣準局負工消費合作杜印製 A7 B7 五、發明説明(24 ) 依本發明所示,注射壓力所保持之壓降係小於一相對應 之捲繞彈簧注射器者,以利較迅速之注射時間。雖然吾人 相k階級狀之氣黃换法像一般氣黄以一氣體活塞穿過兩端 般實用,但是階級狀氣簧仍優於捲繞彈簧,因為氣黄之注 射壓降在注射期間係小於捲繞彈簧者。例如75碎之氣著(大 約之淨輸出值)具有4698mm3之氣簧室,且内徑13mm及長 度為35.4mm,將其加壓至1600psi ’ 一 3mm直徑之第二部份 58b佔用35.4mm之室長度’且在其全伸狀態(中立位置)佔去 250mtn3之空間,大致之施力常數可從截面上之工作壓力計 算得知,亦即7mm部份及3mm部份間之截面積差乘以壓力 (卩1/4(49111〇12-9|111112)^1/645.2 1111112)\1600磅/吋2),以產生 大約78磅,且因密封件中之摩擦而有少許之損失。 當氣簧完全鉴縮時,7mm直徑之第一部份58a佔去室内 23mm之行程即885mm3,而3mm直徑之第二部份58b佔去室 内12.4mm之長度’即88mm3之容積,因此,室在完全伸展 時之容積為4448mm3,而全壓縮量約3725mm3。在形成一 線性惺定階級式之氣簧中,保持氣簧室容積及活塞佔有容 積間之比率在全壓縮時約4 : i以上係十分重要,若比率在此 程度以下’則氣簧即如同一捲繞式彈簧,尤其因為室之容 積較第一活塞部份之佔用空間為小’因此壓縮氣體所需之 力會在其進一步壓縮時増加,相似於捲繞彈簧之壓縮力。 圖10顯示壓力對時間之代表性數據,將本發明之氣簧與 一捲繞彈簧相比較’而圖"概示本發明氣簧比較於一捲繞 彈簧之注射壓力-時間曲線圖,[代表氣簧曲線而I代表捲 -27- 本紙張尺度逋用中HU家揉準(CNS )八4狀(2似297公着) (請先聞讀背面之注意事項再填寫本頁) 、装-----—訂------—:— A7 B7 25 五、發明説明( 繞彈簧曲線,當注射裝置擊發時,不論其使用氣簧或捲繞 彈簧’小瓶室内之壓力在自i點至點時仍相同於大氣壓 力,此持活塞開始移動,直到活塞或撞鎚封閉柱塞及活塞 或撞鎚間之任何空隙,然後壓力自达點至込點以極短時間内 建立’而在射出之前到達峰值£_以確實貫穿表皮。二種型式 之注射器在£_點到£點有顯著之壓降,注射實際上係發生於 £_、4點之間,氣簧注射裝置中最重要之處在於丄點處之壓 力同時對於二種彈簧皆可利用,惟,氣簧在注射期間末期 之壓力遠高於捲繞彈簧者,因此氣簧在其全程注射期間皆 可保持其初期壓力,即其壓損較小。 氣簧之另一優點在於可使用較弱之氣簧,即其具有較低 之初期注射壓力(在i點處)’亦即在捲繞彈簧之狀況下,其 在4點之初期壓力需為較高,以補償注射期間壓力之迅速下 降’避免形成濕性注射。 氣簧注射器之顯著優點在其比較於捲繞式彈簧而可對同 一劑量有較快速之注射週期,因其在預定之注射週期下有 較少之注射壓力損失。 此外,氣簧之另一優點在於壓力輸出並非大幅依賴於活 塞58旎自注射器拉回多少,如囷卜3所示,此指本發明在注 射期間可達到均勻之壓力,而不論劑量多寡,如@卜3,即 使為一-小劑量之注射’只需柱塞3峨小瓶室%及活塞別抽 回V許,可對較大劑量之注射產生相同恆定之恩力輸出, ::抽出較多之活塞,但是捲繞彈簧而言若不移動相當大 又則無法達成’亦即操作注射器之捲繞彈贅需要捲繞彈 -28-
Mm, ( 210X297^* l·I-r-----oi------IT------1¼ (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局属工消費合作,社印装 經濟部中央橾準局負工消費合作社印«. A7 7、發明説明"^ ^- 簧做70全之壓縮,而不管劑量如何。反之,圖U所示實例 中依據待/王射藥物劑量而改變之氣黃能量其能量仍為怪 定’而不論圖4-6實例中之劑量如何,本發明之注射器因而 可涵蓋多種不同之應用及用途。 氣簧相對於捲繞彈簧之另一優點在於旋轉繞之能量較為 平坦,亦即局部壓縮氣簧之旋繞力矩大致相同於完全壓縮 彈簧,另方面,以捲繞彈簧而言,當其進一步壓縮時旋繞 力矩即増加,而輸出係相反於輸入之力。 氣黃之另一優點在於自i點起氣簧不會產生明顯之壓力波 動,而捲繞彈簧必然會有波動,此種波動係滑失或乒乓效 應所致,即捲繞彈簧所生之縱向振動。 氣簧之又一優點在於整個氣簧總成可更換為另一氣簧, 就此而言,不同強度之氣簧皆可替換而不變更注射器之整 禮尺寸,例如75磅之氣簧可換為較強或較弱之氣簧,氣簧 常數可增減而不改變氣簧大小,此可藉由改變D1/D2比值或 增減氣簧室内之壓力而達成,即較高之壓力可造成較強之 氣簧’反之亦然。惟,應注意的是完全壓縮時氣簧室之容 積及活塞佔用室内容積之比率最好約4:1以上,以保持一最 小之壓降,就此而言,氣簧之強度可改變而配合不同型式 之注射,例如皮内及皮下注射以及皮下(肥組織)與筋膜(在 肌肉之上)注射,或甚至通過肌肉至骨膜(骨格周侧之組 織),細孔之直徑可依不同之注射型式而改變。 本發明之另一特性係圈14-17所示之聯結裝置或轉接件 120,用於將一藥物供給瓶122轉接至任一無針注射器之喷 -29- 本纸張尺度適用中國國家揉窣(CNS ) Α4规格(210Χ297公釐) (請先Μ讀背面之注意事項再填寫本頁) 装· 訂 經濟部中央標準局貝工消费合作社印装 A7 ___________Β7____ 五、發明説明() 27 嘴總成20 ’例如其包含,830、,543、,818號美國專利所述之 捲繞彈發操作式注射器,諸案在此可供參考,其另可包含 本發明之氣簧注射器及前述之氣體操作式注射器,其中之 藥物供給瓶122係指任何可裝藥物之容器,不論容器之尺 寸、形狀或結構,例如,878、,483、,113號美國專利所示之 小瓶’以及TUBEX瓶或任意之圓筒形容器。聯結裝置12〇包 含長中空之圓筒形主體124,主體具有一第一端126及一 相對互於第一端126之第二端128,圖中雖揭示一圓筒體, 惟任意之主雜結構皆可用於配合不同型式之喷嘴總成及供 給瓶結構。一具有第一側130A及相對第二侧130B之分隔壁 13〇設於第一、二端126、128之間,第一侧π〇Α較接近第一 端126 ’而第二侧13〇]3較接近第二端128 ; 一中心孔13〇(:穿 刀隔壁130 ’其係對齊於穿過第一側ι3〇Α及第一端ι26間之 尖頂形中空針132 ’供流體自小瓶流過壁130 ’針132在軸向 自第一侧130Α伸向第一端126,但是終端在主體内,使其不 伸出第一端126外,以免意外扎傷。 第一端126具有一藥物供給瓶接頭14〇,可連接於供給瓶 122,但是連接時可防止脫離,特別的是接頭14〇包含瓶座 而且具有一對彈性齒142,各齒142最好呈推拔狀且界定出 瓶、.、„合自由端144,齒142在直徑方向相對且互相向内漸 縮地伸向壁130。較佳實例中,諸端144結合於瓶122之頸部 122A,頸部最好備有裝置121可結合於齒,以免其脫離聯結 裝置,例如頸部122A可具有一槽或一凹部以結合於末端 144,或可具有一備有圖14所示環形槽123之頸部結合套筒 -30- 本紙張认逋用中ϋΗ家榡準(CNS )从狀(2丨Gx297公羡) (請先閲讀背面之注意事項再填寫本頁} ------1--.-----;;裝------訂------旅--=---=-I---- 經濟部中央樣準局貞工消費合作杜印製 A7 B7 五、發明説明(28 ) 121。另者,瓶可在較窄頸部之後設有一擴大之頭部,如 ’878號專利所示,其他可供瓶插入而難以脫落之裝置亦可使 用,即單向連接方式。 當瓶122穿過第一端126時,瓶122之前端(頸部122A)強迫 齒142分開,當頸部或頭部插穿或接近於自由端144時,齒 142即彈回原來結構,即結合於凹部123或較小之頸部 122A,齒心漸縮形迫推結構使凹部123或較大頭部相抵靠, 以防止瓶122在相反方向移出。瓶122之前端插入時,針132 即刺穿其密封件,以利連通至其内之通道132A。 第二端128具有一喷嘴接頭15〇,接頭具有一快拆件152、 152',可在接頭150僅推入噴嘴總成2〇時抓持噴嘴總成2〇之 一部份,其移除時係藉由拉動及/或扭轉。如圖14、16所 示,主體124之周緣可設四個等角度間隔(隔9〇。)之快拆件 152,或如囷16A所示之一對在直徑方向對立之快拆件 152’,囷16A之實例中,各件152ι係相似於圖M、16中之件 152 ’不同的是件152’最好略寬於件152且具有一長孔153以 構成一對相鄰之次件152",各次件係可各自彎曲。快拆件 152、152’延伸平行於主體之縱向,如圖14、16所示,其具 有彈性而可在喷嘴總成插入期間互相膨脹分離,且可在連 接於喷嘴總成時回到原來之鬆釋位置,惟,快拆件152、 152最好在嗜嘴總成連接時略為分開’以施加_抓持力於喷 嘴總成,使總成向内朝向其中性之鬆釋位置。各快拆件 152、152'具有一偟向向内之突出部份或短片ι52Α,可接合 喷嘴總成20而固定之,喷嘴總成可設有四個配合表面、凹 -31 - 本紙張尺度適用中國國家標準(CNS ) A4规格(210X297公釐〉 ^^1 ml I *ιι*·ιν— ίI tn· - \i.·. J* til I * . c (請先閲讀背面之注意事項再填寫本頁) 訂
‘線丨卜 L A7 B7 經濟部中央橾準局貞工消费合作杜印*. 五、發明説明(29 ) 部或刻槽,如囷12、13之編號27所示,其可用於二或四個 快拆件,供突出部份152A佔用其内之空間,並使聯結裝置 固接於噴嘴總成。 聯結裝置另外包含一可拉伸之薄膜密封件16〇,係鄰接於 分隔壁130之第二側130B’密封件160可具有一大致對齊於 中央開口之零直徑孔,零直徑孔係在密封件拉伸後將之刺 穿而形成’如’113號美國專利所示,在此可供參考,惟,密 封件最好具有一開孔。欲緊固配合於密封件16〇時,分隔壁 130之第二側i3〇B備有一環侧槽13〇c,密封件16〇之一側則 具有一坐合於槽130C内之配合環侧部份162。 —環170 (見圖17及20)抵靠於密封件,環係摩擦地結合於 主體124之内壁’使密封件16〇抵靠於壁】30,環170之内周 緣172結構係配合於噴嘴總成之外形,以利喷嘴總成準確對 齊於聯結裝置’當噴嘴總成20接於聯結裝置時,其將密封 件160壓擠於分隔壁130,以利於噴嘴總成及中央開口之間 生水密。 —防護蓋180 (見圖14及21)最好接於聯結裝置,其係結合 於環170及密封件160,以防護及封閉第二端128,蓋18〇具 有四個配合之表面或凹部182,大致相似於喷嘴總成上所設 之凹部27’以配合四或二枚快拆件,凹部182容置短片 152’而將主體124固接於蓋180。 含有藥物供給瓶接頭14〇與噴嘴接頭150之主體124及環 170可由衛生、無毒性、任意藥用塑膠合成物如磺酸聚合 物 '聚碳酸酯樹脂、MOBAY MARKOLON 2658、GE -32- 本紙張尺度適用中國國家標率(CNS > A4规格(210X297公釐) (請先《讀背面之注意事項再填寫本頁) -裝· 、*τ --諫 A7 B7 五、發明説明(30 ) LEXAN GR1310或等效物或任意相容於藥物之藥用合成物所 製成,密封件160最好由天然或人造橡膠或類似物製成。 連接件可由接合或分開之蓋180包覆,若蓋欲接合則其先 自主體124斷接’ 一藥物供給瓶122再接於主體14〇之另端, 當瓶子插入時,若不施力則無法移除,另者,瓶子可先接 於主禮,然後主體與瓶子在蓋移開之後可接於噴嘴總成。 當噴嘴總成接於聯結裝置時,密封件160中之孔即對齊於喷 嘴總成中所設之細孔24,操作時瓶子及注射裝置皆呈直立 狀,以利小瓶室中之空氣自細孔溢出,當柱塞抽離噴嘴總 成時,室26中產生真空而將藥物自瓶子122抽至中空針 132。抽取所需之藥物量後’聯接裝置即斷接於注射器,且 以蓋子封閉密封件160中所設之開孔,連接裝置連同瓶子可 留存做再次使用,或依藥物指示而立即棄置,當瓶子空置 時連接裝置即可隨後瓶子丟棄。 本發明之聯結裝置提供較低之成本,以及將藥物供給瓶 接合於注射孔之可棄置裝置^ 本發明之另一特性在於一氣槍或一裝置,其係利用上述 階級或氣簧迅速加壓空氣,而發射出一可投射物,其壓縮 室中需產生一均勻壓力,壓縮氣體即可將彈丸排出筒外。 如’517號美國專利所tf ’在高能量時不均勻加速所生之熱壓 縮氣流極易使彈丸偏曲,因而影響其準度,此外,習知之 活塞彈跳問題類似於上述之滑失者,其在氣槍或彈發操作 式槍中極為普遍,此問題應對準度具有不良影響,而此種 彈跳係因積存於活塞冠部及外缸前端壁間之空氣在活塞聲 -33- 本纸張尺度適用中國國家標準(CNS > A4规格(210X297公釐) (請先閲讀背面之注意事項再填寫本頁) .裝·
.1T 經濟部中央樣準局員工消費合作社印装
經濟部中央橾準局貝工消费合作社印«. 發衝程之末期所引起。 前述二個問題皆可由本發明加以解決,如前所述,本發 明之氣簧可產生一大致均勻之輸出壓力,因而可均勻地施 加壓縮力於擊發室;此外,由於氣簧中儲存之能量伍定, 不同於習知之氣槍,活塞彈跳可因擊發室中積存之空氣為 較大之150至200磅彈力而避免發生,使用本發明氣著之氣 槍實例係詳示於圖18、19。 所述之氣槍包含一設於擊發機構310前方之圓筒3〇〇’而 機構係安裝於一槍托303上,本發明之擊發機構包含一外中 空缸體320、一中空活塞330及一氣簧50,,外中空缸體32〇具 有一備有排出孔324之前端壁322及一固接於承接件329或類 似物之圓筒形侧壁326’缸禮3 20内可供中空活塞33Q滑移。 中空活塞330具有一请形活塞壁332,並以一突耳334自其外 側伸出’如圖18、19所示;侧壁326備有一縱向長孔328, 可供突耳在縱向向外移動;侧壁332之一端具有一封閉端活 塞壁336,而相對端則呈開口狀,活塞壁332之外侧具有至 少一Ο形封環338或類似物。一擊發室340係由前端壁3 22、 封閉端壁336及侧壁326所界定,擊發時其内部積存之空氣 即經壓縮’囷中雖未揭示’但是中空活塞亦可具有—柔軟 之環緣密封件,如’686號美國專利所示。 氣簧50'大致相似於圖7所示者,中空活塞330係固接於較 大活塞部份58a'之自由端,使活塞58,與中空活塞330—禮移 動’為了應用於氣槍中’氣簧可加壓至15〇〇至250〇psi,以 產生150至200碎之氣簧常數’較高或較低之恩力亦可,此 34- 本紙張尺度適用中國國家樑準(CNS ) A4规格(210X297公釐) {請先閲读背面之注意事項鼻填寫本頁) -装. 訂 經濟部中央揉準扃貞工消费合作社印装 A7 ____ B7______ 五、發明説明(32 ) 依其用途而定,亦即高速排出一投射物時需要較大壓力, 反之亦然。 圓筒300可依一樞銷302或類似物樞轉,以供園筒裂口 304 開啟,圓筒係利用依箭頭方向308相對於槍托301樞轉而開 啟,以利通向裂口做投射物或彈丸306填入及清潔圓筒,裂 口具有一 Ο形封環305或類似物,使擊發室340及圓筒之孔 301間呈氣密。 圓筒300在操作時係聯結於一扳機槓样機構310,因此當 裂口因圓筒依箭頭方向3 08樞轉時即可開啟,槓样機構3 10 依箭頭方向314移動,使中空活塞330成為18所示狀態,尤 其槓样機構之一端312抵靠於突耳334,直到一觸發機構350 結合於較小活塞部58b'—端上所設之刻槽72’為止。一止動 件360設於或接於承接件329上,使其相鄰於且接於氣簧50’ 之突緣57·,以防止氣簧在扳上步驟期間向後移,觸發機構 350保持氣簧鎖定於圖18所示之狀態,直到擊發為止。 圖中雖未揭示,惟此空氣槍之扳機機構可為一分離式槓 桿,此外,扳機機構雖近似於本發明注射器中之作動機構 90,用於將中空活塞330向後拉離前端壁322,以利調整能 量設定。 藉由將中空活塞33 0移至圖18所示狀態,較大之活塞部份 58a'即受迫進入氣簧室5Γ’再者,由於較大活塞部份58a·之 容積大於圖19所示較小活塞部份58b'佔用時之中性延伸狀態 者,因此,氣簧室5Γ可進一步加壓。當槍擊發時,即釋放 活塞58時,活塞58及中空活塞330在氣簧施力下迅速朝向前 -35- 本纸張尺度適用中國國家標準(CNS ) A4规格(210X297公釐) (請先閲讀背面之注$項再填寫本页)
C 裝. 33五、發明説明( A7 B7 經濟部中央橾準局貝工消费合作杜印裝 端壁322加速,擊發室34〇中之空氣増加壓縮,直到其超過 閘值,即彈丸排出裂口外且通過圓筒。 此外,雖然本發明注射器及氣槍利用一階級式氣簧為 例,而氣簧活塞58、58,可移動定位及套筒52、52,固定, 惟丄本發明亦可涵蓋固定之階級狀氣簧活塞Μ、58,及可移 動疋位之套筒52、52’,此時,注射器之柱塞3〇在操作時可 由套筒排送,而於末端處較小活塞部份58b穿過套筒52,為 了配合活塞,一圓筒形驅動套筒(圖中未示)可與活塞同軸向 地設置,使驅動套筒排送柱塞3〇β同樣,氣簧5〇,可反向定 使中空活塞330由套筒52,堪動,而在末端處較小活塞部 份58b’穿過套筒,例如此可利用將中空活塞33〇之開口端部 接於供較小活塞部份58b,穿過之套筒末端而達成。 雖然本發明已由階級狀氣簧說明其較佳實例,但是任意 足非階級狀氣簧皆可用於本發明之無針注射器及氣搶類 似<氣簧可見於泰勒等人之專利内,其即可結合於本發明 注射器中,其他習知之氣簧(無活塞穿過二端之非階級式)如 工業用氣簧公司所製者,其亦生產階級狀氣簧。例如,注 射器可使用僅具有第一活塞部份58a而另端封閉之氣簧套 筒52可固定,而利用第一活塞端接於柱塞,作動機構可如 圖4-6所示方式連接,以將活塞推入氣簧室,觸發機構則結 合於套筒及活塞末端間之第一活塞部份。 應瞭解的是本發明精神範疇内之變化及修改可供習於此 技者為之,例如注射器可改為將固體藥物注入皮内或射出 一投射物。緣是,習於此技者自本文中所取得之修改皆在 (請先閲讀背面之注意事項再填寫本頁) --裝 -訂 線 -36- 經濟部中央橾準局員工消费合作社印袈 A7 B7 五、發明説明(Μ ) 本發明之精神範疇内,即成為本發明之另一實例,據此, 本發明之範圍係界定如申請範圍者。 圖式主要元件之標號說明 10 無針注射系統 32 撞鎚 20 喷嘴總成 34 間隙 20A 喷嘴總成 36 慣性重物 20B 喷嘴總成 40 動力機構 22 喷嘴件 50 » 50' 氣簧 24 細孔 51 > 51' 氣簧室 25 梯形螺紋 52,52, 套筒 26 小瓶室 54,56 端塞 27 槽 55,57 止動緣 28 正圓錐件 57, 唇 28, 凸錐件 58,58' 活塞 29 止動件 58a 第一活塞部份 30 柱塞 58a, 較大活塞部份 30a 彈性扣接頭 58b 第二活塞部份 30b 叉形件 58b, 較小活塞部份 30c 主體部份 58c 連接部份 30d 橫伸段或短片 58d 肩部 30e,30f, 30g 端壁 59 鄰靠滾子 30A,30B ,30C柱塞 62,63 0形環 31 轴 64 第二密封件 -37- 本紙張尺度適用中國國家揉準(CNS ) A4规格(210X297公釐) l·-------0¾.II (請先W讀背面之注意事項再填寫本頁) 訂 A7 B7 五、發明説明(% ) 〇〇 經濟部中央標準局負工消费合作社印装 64a 碟片 122A 頸部 64b 華司 123 環形槽 66 第三密封件 124 圓筒形主體 66a 碟片 126 第一端 66b 固定件 128 第二端 70 聯結機構 130 分隔壁 72 觸發結合刻槽 130A 第一侧 72, 刻槽 130B 第二侧 90,90A 作動機構 130C 中心孔 92,92A 套筒部份 132 中空針 94,94A 配合之螺紋 132A 通道 100 觸發總成 140 藥物供給瓶接頭 102 閂殼體套筒 142 彈性齒 103 内侧壁表面 144 瓶結合自由端 104 侧壁孔 150 噴嘴接頭 106 圓珠 152,152, 快拆件 108 钮 152" 次件 109 内壁 152A 徑向突出短片 110 環形槽 153 長孔 112 閂珠固定杯 158 鄰靠滾子 114 壓縮彈簧 160 薄膜密封件 120 聯結裝置 162 環侧部份 121 頸部接合套筒 170 環 122 藥物供給瓶 172 内周緣 -38- - --11111} ;^__ (請先閲讀背面之注意Ϋ項再填寫本頁) 訂 本紙張A度適用中國a家標準(CNS > A4规格(210X297公釐) A7 B7 五、發明説明(36 ) 經濟部中央樣準局貝工消费合作社印製 180 防護蓋 314 箭頭方向 182 蓋之配合表面或凹部 320 中空缸體 200 , 200Α 殼體 322 前端壁 210 腔 324 排出孔 220 , 220Α 殼體螺紋部份 326 侧壁 300 圓筒 328 縱向長孔 301 孔 329 承接件 302 樞銷 330 中空活塞 303 搶托 332 活塞壁 304 圓筒裂口 334 突耳 305 Ο形封環 336 封閉端壁 306 彈丸 338 0形封環 308 箭頭方向 340 擊發室 310 板機槓样機構 350 觸發機構 312 槓样機構之一端 360 止動件 -39- (請先Μ讀背面之注意事項再填寫本買) .裝- 訂 球 • —1. 本紙張尺度適用中國國家標準(CNS )八4规格(210Χ297公釐)

Claims (1)

  1. 經濟部中央橾隼局属工消费合作社印簟 A8 B8 C8 D8 π、申請專利範圍 1. 一種用於注射藥物之裝置,包含: 一喷嘴總成,具有一小瓶室可留置藥物,該啧嘴總成中 之一細孔係與小瓶室成流體連通,供藥物通過該細孔, 及有一壓力壁件設於該留置藥物之室内,且可在小瓶室 内移動;及 一動力機構,其與該壓力壁件可作動的連接’且以一足 以將受一壓力作用之藥物由小瓶室射出之速度移動該壓 力壁件,該壓力足以刺穿至少一層皮膚,該動力機構包 含一氣簧。 2. 根據申請專利範圍第1項之裝置,其中氣簧包含一密封之 氣簧壓力室,係具有一可滑動地貫穿之活塞且容置一加 壓之氣體,及 其中裝置另包含一觸發機構,可在操作上選擇地結合及 脫離於活塞,以利選擇地將氣簧固定於鎖定之壓縮狀 態,並且選擇地將氣簧釋放至其鬆釋狀態,及一氣簧聯 結機構,係接於活塞之一近端且-由觸發機構容置,及 其中噴嘴總成及氣簧在操作上係位於一殼體構件内。 3..根據申請專利範圍第2項之裝置,其中活塞之一遠端大於 近端,且近端之至少一部份係在壓力室處於鬆釋狀態時 位於壓力室内,壓力室内之加壓氣體則在遠端移入室内 時做進一步壓縮,及 其中動力機構另包含一可移動地接於殻體構件之作動 件,使作動件可在縱向相對於氣簧壓力室移動,且其中 作動件可將活塞之遠端移入壓力室及將氣簧聯結機構移 -40- 本纸aui度逋用中國國家揉準(CNS > Α4规格(210X297公釐) ------- (請先聞讀背面之注意事項再填寫本頁) 言
    A8 B8 C8 D8 經濟部中央橾率局貝工消費合作社印裝 申請專利範圍 入觸發機構,使氣簧保持在壓縮狀態β 4·禪據申請專利範圍第3項之裝置,其中噴嘴總成可拆接於 殼體構件,其中活塞在操作上可拆接於壓力壁件,該壓 力壁件係一柱塞’且其中一空轉連接機構設於活塞及柱 塞之間,使活塞在觸及—柱塞之番可沿一預定距離移動。 5.根據申請專利範圍第4項之裝置,其中空轉連接機構包含 一界定出一縱向長孔且接至活塞之撞鎚,其中柱塞另包 含一連接軸,可在操作上滑動地容置於該長孔内,並具 有 預疋長度而可在該柱.塞端.及該-接.鍵·τ~端之間提供 預定之空隙,其中該:撞鍵端」1於移過該空隙後才結合於 該柱塞。、 根據申請專利範圍.第4項之裝置,其中空轉連接機構包含 一設於柱塞及活塞間之彈性快拆接頭.,該快拆接頭係自 該柱塞伸出且包含多數之彈性叉件,其中設於活塞上之 一擴大頭部係由該彈性叉件做滑動容置,其中各叉件具 有一在徑向向内延伸之短片’以—利限制擴大頭部之縱向 移動,因此當柱塞容置於該室_内時’又件不致於在徑向 向外伸出,以利將換大頭固定於快拆接頭内,及 其中當噴嘴總成自裝置移除時,該又件露出供使用者操 作’使柱塞可分離於活塞。 7.根據申請專利範圍第4項之裝置,其中噴嘴總成預先填注 入藥物,且其中噴嘴總成或柱塞或二者係由不鋒鋼、聚 碳酸醋、聚丙稀·及其衍生物所製成’或由·相容於藥物且 可承受其所受壓力與應力之其他適當塑膠、玻璃或合成 -41 - 私纸張尺度逋用中國國家梂準(CNS ) Μ规格(21〇X297公釐) (請先聞讀背面之注$項再填寫本肓) 訂
    '申請專利範圍 物所製成。 8.根據申請專利範圍第2項之裝置,其中密封之氣簧壓力室 係由一管狀套筒及一對密封住該管狀套筒之端突耳所界 定’且其中該活塞可滑動地容置於端突耳之間。 9·根據申請專利範園第1項之裝置,其另、包含一將藥物供給 瓶接至噴嘴總成之聯結裝置,該聯結裝置包含: —概呈中空之主禮,其具有一近端及一遠端; 一分隔壁,設於近、遠端之間,該壁具有一近侧及一遠 侧’且一孔由該分隔壁界定; —中空針’係在轴向自分隔..壁之遠端仲—向主趙之遠端, 且終端在主體内,因此該針仍在主體内且對齊於該孔, 以利流禮在其間流通; 一藥物供給瓶,係接於主體之遠端上:使供給瓶可插入 瓶之接頭,且防止供給瓶於其後移除; 一喷嘴接頭,設於該近端上,其中該嘴嘴接頭具有多數 之快:拆件’可在該接頭移向該噴嘴|成後連接於該喷嘴 總成之一部份,且可在施加足夠之分離力時自該喷嘴總 成分離,且其中該針在該供給-瓶接於該噴嘴接頭時刺穿 該供给瓶上之一密封件。 10.根據申請專利範圍第_9項之裝置,其冲聯結裝置另包含一 鄰接於該壁近侧之可拉伸薄膜密封件,該密封件具有一 大致對齊於該孔之開孔或零直徑孔; 一環,鄰接於該密封件,其中該環備有該喷嘴總成之一 結構,以供其插入;及 -42- 本紙張尺度逋用中國國家棣準(CNS ) A4规格(210X297公釐) -J--------.rv — (請先Ktfc背面之注意事項再填寫本頁) 訂· 經濟部中央橾隼局負工消费合作社印装 __Γ A8 B8 C8 D8 申請專利範圍 -防護蓋’用於防護及封閉該近端,其中該蓋具有至少 一配件,用於結合該快拆件。 11·根據中請專利範圍第9項之裝置,其中藥物供給瓶接頭包 含至少-枚伸向該壁之兹’其中該齿之—自由端結合該 供給瓶之一部份,其中該瓶部份具有可結合於該齒之裝 置’以防止該供給瓶自此移除; 其中喷嘴接頭上之該快拆件大致在該主體之軸向延伸, 且其具有彈性可供該快拆件在徑向脹離該喷嘴,而在完 全相揍時可大致回復至其原來位置;及 其中各該釋放件具有一在徑向向内伸出之短片,該短片 結合於該噴嘴總成,以供該聯結裝置與之相接。 J — (請先《讀背面之注f項再填寫本頁) 訂- 經濟部_央樣隼局負工消费合作社印裝 -43 - 本紙張尺度逋用中國B家揉準(CNS ) A4洗格(210X297公釐) » 1^1 In
TW85100851A 1995-01-09 1996-01-25 Device for injecting medical product TW387814B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/369,812 US5599302A (en) 1995-01-09 1995-01-09 Medical injection system and method, gas spring thereof and launching device using gas spring

Publications (1)

Publication Number Publication Date
TW387814B true TW387814B (en) 2000-04-21

Family

ID=23457035

Family Applications (1)

Application Number Title Priority Date Filing Date
TW85100851A TW387814B (en) 1995-01-09 1996-01-25 Device for injecting medical product

Country Status (8)

Country Link
US (4) US5599302A (zh)
EP (1) EP0802809B1 (zh)
JP (1) JPH10512165A (zh)
AT (1) ATE237380T1 (zh)
AU (1) AU4693596A (zh)
DE (1) DE69627474D1 (zh)
TW (1) TW387814B (zh)
WO (1) WO1996021482A2 (zh)

Families Citing this family (626)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2152323T3 (es) * 1993-07-31 2001-02-01 Weston Medical Ltd Inyector sin aguja.
FR2718357B1 (fr) * 1994-04-06 1997-10-03 Defarges Alain Moreau Perfectionnements apportés à un dispositif d'injection par jet sans aiguille.
US6474369B2 (en) 1995-05-26 2002-11-05 Penjet Corporation Apparatus and method for delivering a lyophilized active with a needle-less injector
US5899879A (en) * 1995-12-19 1999-05-04 Genesis Medical Technologies, Inc. Spring-actuated needleless injector
US5800388A (en) 1996-02-29 1998-09-01 Medi-Ject Corporation Plunger/ram assembly adapted for a fluid injector
US5921967A (en) 1996-02-29 1999-07-13 Medi-Ject Corporation Plunger for nozzle assembly
US5769138A (en) * 1996-04-01 1998-06-23 Medi-Ject Corporation Nozzle and adapter for loading medicament into an injector
US6374255B1 (en) 1996-05-21 2002-04-16 Immersion Corporation Haptic authoring
US6458574B1 (en) 1996-09-12 2002-10-01 Transkaryotic Therapies, Inc. Treatment of a α-galactosidase a deficiency
US5875976A (en) * 1996-12-24 1999-03-02 Medi-Ject Corporation Locking mechanism for nozzle assembly
US7347840B2 (en) * 2000-03-02 2008-03-25 Pyng Medical Corp. Patch for locating a target zone for penetration
US6761726B1 (en) * 1998-05-15 2004-07-13 Pyng Medical Corp. Method and apparatus for the intraosseous introduction of a device such as an infusion tube
US5911703A (en) * 1997-05-22 1999-06-15 Avant Drug Delivery Systems, Inc. Two-stage fluid medicament jet injector
US6030399A (en) * 1997-06-04 2000-02-29 Spectrx, Inc. Fluid jet blood sampling device and methods
US5947928A (en) * 1997-06-19 1999-09-07 Mile Creek Capital, Llc Drug delivery system
US6004287A (en) * 1997-09-23 1999-12-21 Loomis; Dale J Biolistic apparatus for delivering substances into cells and tissues
US6071272A (en) * 1997-10-28 2000-06-06 Hoffman; Alan S. Method for treating erectile dysfunctionality
US6256011B1 (en) 1997-12-03 2001-07-03 Immersion Corporation Multi-function control device with force feedback
US6610042B2 (en) 1997-12-05 2003-08-26 Felton Medical, Inc. Disposable unit-dose jet-injection syringe for pre-filled and/or transfilled liquid injectable medical drug or vaccine products and method thereof
US6503231B1 (en) * 1998-06-10 2003-01-07 Georgia Tech Research Corporation Microneedle device for transport of molecules across tissue
WO1999064580A1 (en) * 1998-06-10 1999-12-16 Georgia Tech Research Corporation Microneedle devices and methods of manufacture and use thereof
CN1320050A (zh) * 1998-07-27 2001-10-31 梅迪-杰克特公司 用于药物注射器装置的充药机构
DE69933569T2 (de) 1998-07-27 2007-06-28 ANTARES PHARMA, Inc., Minneapolis Injektionshilfstorpedo für ein medizinisches injektionssystem
US6428528B2 (en) * 1998-08-11 2002-08-06 Antares Pharma, Inc. Needle assisted jet injector
JP2000107289A (ja) * 1998-10-05 2000-04-18 Showa Yakuhin Kako Kk カートリッジ式歯科用注射器ユニット
US6506177B2 (en) * 1998-10-14 2003-01-14 Sergio Landau Needle-less injection system
US6406455B1 (en) * 1998-12-18 2002-06-18 Biovalve Technologies, Inc. Injection devices
DE19859137C1 (de) * 1998-12-21 2000-05-18 Ferton Holding Sa Ejektionsgerät zur Hochdruckejektion einer Flüssigkeit
US6258062B1 (en) * 1999-02-25 2001-07-10 Joseph M. Thielen Enclosed container power supply for a needleless injector
US7060048B1 (en) * 1999-04-16 2006-06-13 Powerject Research Limited Needleless syringe
AU4656000A (en) * 1999-04-22 2000-11-10 Gilbert Garitano Needleless permanent makeup and tattoo device
US7171264B1 (en) * 1999-05-10 2007-01-30 Genetronics, Inc. Intradermal delivery of active agents by needle-free injection and electroporation
US7192713B1 (en) 1999-05-18 2007-03-20 President And Fellows Of Harvard College Stabilized compounds having secondary structure motifs
EP1754488A1 (en) 1999-05-24 2007-02-21 Introgen Therapeutics, Inc. Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases
US6743211B1 (en) * 1999-11-23 2004-06-01 Georgia Tech Research Corporation Devices and methods for enhanced microneedle penetration of biological barriers
US6611707B1 (en) 1999-06-04 2003-08-26 Georgia Tech Research Corporation Microneedle drug delivery device
US7074210B2 (en) * 1999-10-11 2006-07-11 Felton International, Inc. Universal protector cap with auto-disable features for needle-free injectors
ATE285806T1 (de) 1999-10-11 2005-01-15 Felton International Inc Universelle antiinfektionsschutzvorrichtung für nadellose injektoren
US20020193740A1 (en) 1999-10-14 2002-12-19 Alchas Paul G. Method of intradermally injecting substances
US6776776B2 (en) 1999-10-14 2004-08-17 Becton, Dickinson And Company Prefillable intradermal delivery device
US6569123B2 (en) 1999-10-14 2003-05-27 Becton, Dickinson And Company Prefillable intradermal injector
US6569143B2 (en) 1999-10-14 2003-05-27 Becton, Dickinson And Company Method of intradermally injecting substances
US6843781B2 (en) * 1999-10-14 2005-01-18 Becton, Dickinson And Company Intradermal needle
US6494865B1 (en) 1999-10-14 2002-12-17 Becton Dickinson And Company Intradermal delivery device including a needle assembly
US6382204B1 (en) * 1999-10-14 2002-05-07 Becton Dickinson And Company Drug delivery system including holder and drug container
US6673035B1 (en) * 1999-10-22 2004-01-06 Antares Pharma, Inc. Medical injector and medicament loading system for use therewith
CA2387893C (en) * 1999-10-22 2009-04-14 Antares Pharma, Inc. Medical injector and medicament loading system for use therewith
US6391003B1 (en) 1999-10-25 2002-05-21 Antares Pharma, Inc. Locking mechanism for a jet injector
US7887506B1 (en) 1999-11-23 2011-02-15 Pulse Needlefree Systems, Inc. Safety mechanism to prevent accidental patient injection and methods of same
US6770054B1 (en) 1999-11-23 2004-08-03 Felton International, Inc. Injector assembly with driving means and locking means
US7029457B2 (en) * 1999-11-23 2006-04-18 Felton International, Inc. Jet injector with hand piece
US6693626B1 (en) 1999-12-07 2004-02-17 Immersion Corporation Haptic feedback using a keyboard device
WO2001051109A1 (en) * 2000-01-07 2001-07-19 Biovalve Technologies, Inc. Injection device
CA2331030A1 (en) * 2000-02-16 2001-08-16 Roche Diagnostics Gmbh Hypodermic needleless injection system
US6689092B2 (en) * 2000-03-03 2004-02-10 Boehringer International Gmbh Needle-less injector of miniature type
AU2001247721A1 (en) * 2000-03-23 2001-10-03 Antares Pharma, Inc. Single use disposable jet injector
GB0008494D0 (en) 2000-04-07 2000-05-24 Secr Defence Microprojectile delivery system
US10293056B1 (en) 2000-05-24 2019-05-21 Board Of Regents, The University Of Texas System Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases
US6629958B1 (en) 2000-06-07 2003-10-07 Ronald P. Spinello Leak sealing needle
US6406456B1 (en) 2000-06-08 2002-06-18 Avant Drug Delivery Systems, Inc. Jet injector
EP1298980A2 (en) * 2000-07-10 2003-04-09 Peter M. Wild Woody plant injection method and apparatus
US6695817B1 (en) 2000-07-11 2004-02-24 Icu Medical, Inc. Medical valve with positive flow characteristics
DE10034270A1 (de) * 2000-07-14 2002-02-14 Disetronic Licensing Ag Vorratsbehältnis mit einer Dosiereinrichtung zur dosierten Abgabe eines injizierbaren Produkts an ein Injektionsgerät
GB0022742D0 (en) 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
US6610033B1 (en) * 2000-10-13 2003-08-26 Incept, Llc Dual component medicinal polymer delivery system and methods of use
US7575924B2 (en) 2000-11-13 2009-08-18 Research Development Foundation Methods and compositions relating to improved lentiviral vectors and their applications
AU2003222427B8 (en) * 2000-11-17 2010-04-29 Vascular Biogenics Ltd. Promoters exhibiting endothelial cell specificity and methods of using same
US8071740B2 (en) * 2000-11-17 2011-12-06 Vascular Biogenics Ltd. Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
EP1339442A4 (en) * 2000-11-30 2006-12-27 Biovalve Technologies Inc INJECTION SYSTEMS
CA2429769C (en) * 2000-12-07 2016-04-26 Board Of Regents, The University Of Texas System Methods of treatment involving human mda-7
WO2002064193A2 (en) 2000-12-14 2002-08-22 Georgia Tech Research Corporation Microneedle devices and production thereof
WO2002074336A2 (en) 2001-02-23 2002-09-26 Glaxosmithkline Biologicals S.A. Influenza vaccine formulations for intradermal delivery
WO2002074406A1 (en) 2001-03-14 2002-09-26 Penjet Corporation System and method for removing dissolved gas from a solution
GB0109297D0 (en) 2001-04-12 2001-05-30 Glaxosmithkline Biolog Sa Vaccine
US20050192530A1 (en) * 2001-04-13 2005-09-01 Penjet Corporation Method and apparatus for needle-less injection with a degassed fluid
US6613010B2 (en) 2001-04-13 2003-09-02 Penjet Corporation Modular gas-pressured needle-less injector
US6755220B2 (en) 2001-04-27 2004-06-29 Penjet Corporation Method and apparatus for filling or refilling a needle-less injector
MY134424A (en) 2001-05-30 2007-12-31 Saechsisches Serumwerk Stable influenza virus preparations with low or no amount of thiomersal
US20100221284A1 (en) 2001-05-30 2010-09-02 Saech-Sisches Serumwerk Dresden Novel vaccine composition
US6752781B2 (en) * 2001-06-08 2004-06-22 Sergio Landau Durable hypodermic jet injector apparatus and method
DE10129583A1 (de) * 2001-06-20 2003-01-09 Disetronic Licensing Ag Vorrichtung und Verfahren zu Injektion
EP1416986A4 (en) * 2001-06-29 2005-12-14 Becton Dickinson Co INTRADERMIC DISTRIBUTION OF VACCINES AND GENE THERAPEUTIC AGENTS VIA MICROCANNULE
US20060018877A1 (en) * 2001-06-29 2006-01-26 Mikszta John A Intradermal delivery of vacccines and therapeutic agents
JP4792670B2 (ja) * 2001-07-23 2011-10-12 株式会社島津製作所 針無注射器
EP1412493B1 (en) 2001-08-02 2011-10-05 Institut Clayton De La Recherche Methods and compositions relating to improved lentiviral vector production systems
CA2456484A1 (en) 2001-08-17 2003-02-27 Antares Pharma, Inc. Administration of insulin by jet injection
US7615234B2 (en) 2001-09-11 2009-11-10 Glide Pharmaceutical Technologies Limited Drug delivery technology
GB2404865B (en) * 2001-09-11 2005-09-28 Caretek Medical Ltd Novel drug delivery technology
GB2391480B (en) * 2002-08-05 2007-02-28 Caretek Medical Ltd Drug delivery system
WO2003024507A2 (en) * 2001-09-19 2003-03-27 Biovalve Technologies, Inc. Microneedles, microneedle arrays, and systems and methods relating to same
AU2002330083A1 (en) * 2001-09-21 2003-04-01 Biovalve Technologies, Inc. Gas pressure actuated microneedle arrays, and systems and methods relating to same
CA2500453A1 (en) * 2001-09-28 2003-04-03 Biovalve Technologies, Inc. Microneedle with membrane
US20030135166A1 (en) * 2001-09-28 2003-07-17 Gonnelli Robert R. Switchable microneedle arrays and systems and methods relating to same
IL161229A0 (en) * 2001-10-02 2004-09-27 Inst Clayton De La Rech Methods and compositions relating to restricted expression lentiviral vectors and their applications.
EP2277887A3 (en) 2001-10-19 2011-02-16 Vascular Biogenics Ltd. Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
US6824526B2 (en) 2001-10-22 2004-11-30 Penjet Corporation Engine and diffuser for use with a needle-less injector
GB0125506D0 (en) * 2001-10-24 2001-12-12 Weston Medical Ltd Needle free injection method and apparatus
US6607510B2 (en) * 2001-11-09 2003-08-19 Bioject Medical Technologies Inc. Disposable needle-free injection apparatus and method
US20030130614A1 (en) * 2002-01-09 2003-07-10 Johnson Lanny L. Device for delivering liquid medications or nutrients and gases to local tissue
GB2384527B (en) * 2002-01-23 2004-07-14 Bespak Plc Dispensing device
US6875205B2 (en) 2002-02-08 2005-04-05 Alaris Medical Systems, Inc. Vial adapter having a needle-free valve for use with vial closures of different sizes
KR20040103930A (ko) 2002-02-11 2004-12-09 앤태어스 파머, 인코퍼레이티드 피내 주사기
US20040009939A1 (en) * 2002-03-05 2004-01-15 Board Of Regent, The University Of Texas System Methods of enhancing immune induction involving MDA-7
US6904823B2 (en) 2002-04-03 2005-06-14 Immersion Corporation Haptic shifting devices
US7332469B2 (en) 2002-04-05 2008-02-19 Board Of Regents The University Of Texas System Intrapleural single-chain urokinase alone or complexed to its soluble receptor protects against pleural adhesions
EP1503788B1 (en) 2002-04-25 2011-06-29 Shire Human Genetic Therapies, Inc. Treatment of alpha-galactosidase a deficiency
JP4343708B2 (ja) * 2002-04-26 2009-10-14 アンスティテュ ナシナル ドゥ ラ サントゥ エ ドゥ ラ ルシェルシェ メディカル−イ.エヌ.エス.ウ.エール.エム. 改良型キメラ糖タンパク質と、類型化されたレンチウイルス
US20040025420A1 (en) * 2002-05-09 2004-02-12 Peter M. Wild Injection needle for injecting woody plants
US6942638B1 (en) * 2002-05-30 2005-09-13 Kerry Quinn Needleless injector and ampule system
US20070049945A1 (en) 2002-05-31 2007-03-01 Miller Larry J Apparatus and methods to install, support and/or monitor performance of intraosseous devices
US8641715B2 (en) 2002-05-31 2014-02-04 Vidacare Corporation Manual intraosseous device
US11337728B2 (en) 2002-05-31 2022-05-24 Teleflex Life Sciences Limited Powered drivers, intraosseous devices and methods to access bone marrow
WO2008033873A2 (en) 2006-09-12 2008-03-20 Vidacare Corporation Medical procedures trays and related methods
US8690791B2 (en) 2002-05-31 2014-04-08 Vidacare Corporation Apparatus and method to access the bone marrow
US8142365B2 (en) * 2002-05-31 2012-03-27 Vidacare Corporation Apparatus and method for accessing the bone marrow of the sternum
US9314228B2 (en) 2002-05-31 2016-04-19 Vidacare LLC Apparatus and method for accessing the bone marrow
WO2008033871A2 (en) * 2006-09-12 2008-03-20 Vidacare Corporation Apparatus and methods for biopsy and aspiration of bone marrow
US8668698B2 (en) 2002-05-31 2014-03-11 Vidacare Corporation Assembly for coupling powered driver with intraosseous device
US7811260B2 (en) * 2002-05-31 2010-10-12 Vidacare Corporation Apparatus and method to inject fluids into bone marrow and other target sites
US7951089B2 (en) 2002-05-31 2011-05-31 Vidacare Corporation Apparatus and methods to harvest bone and bone marrow
US9072543B2 (en) 2002-05-31 2015-07-07 Vidacare LLC Vascular access kits and methods
CA2898210C (en) * 2002-05-31 2018-11-13 Vidacare Corporation Apparatus and method to access bone marrow
US11298202B2 (en) 2002-05-31 2022-04-12 Teleflex Life Sciences Limited Biopsy devices and related methods
US10973545B2 (en) 2002-05-31 2021-04-13 Teleflex Life Sciences Limited Powered drivers, intraosseous devices and methods to access bone marrow
US10973532B2 (en) 2002-05-31 2021-04-13 Teleflex Life Sciences Limited Powered drivers, intraosseous devices and methods to access bone marrow
US20040079169A1 (en) * 2002-07-03 2004-04-29 Peter Wild Plant injection method and apparatus
EP2269619A1 (en) 2002-08-12 2011-01-05 Jennerex Biotherapeutics ULC Methods and compositions concerning poxviruses and cancer
US8917234B2 (en) 2002-10-15 2014-12-23 Immersion Corporation Products and processes for providing force sensations in a user interface
JP2006504482A (ja) * 2002-11-01 2006-02-09 アンタレス・ファーマ・インコーポレーテッド 噴射式注射によるインスリン投薬
WO2004048583A2 (en) * 2002-11-22 2004-06-10 Institut Clayton De La Recherche Compositions and systems for the regulation of genes
ES2686775T3 (es) 2003-01-31 2018-10-19 Mount Sinai School Of Medicine Of New York University Terapia de combinación para tratar trastornos de deficiencia de proteínas
CA2518150C (en) * 2003-03-03 2015-08-11 Board Of Regents, The University Of Texas System Methods and compositions involving mda-7
US6802455B1 (en) * 2003-03-26 2004-10-12 Willie V. Evans Atomizer
FR2853837B1 (fr) * 2003-04-16 2006-01-13 Crossject Dispositif de liaison d'un reservoir de principe actif sur une buse d'injection dans un dispositif d'injection dudit principe actif
CA2525017A1 (en) * 2003-05-09 2004-12-23 Anges Mg, Inc. Needleless syringe having medical agent accommodated therein
WO2005026375A2 (en) 2003-05-22 2005-03-24 Fraunhofer Usa, Inc. Recombinant carrier molecule for expression, delivery and purification of target polypeptides
US9504477B2 (en) 2003-05-30 2016-11-29 Vidacare LLC Powered driver
US8992322B2 (en) 2003-06-09 2015-03-31 Immersion Corporation Interactive gaming systems with haptic feedback
HU225252B1 (hu) * 2003-08-21 2006-08-28 S Istvan Lindmayer Tû nélküli injekciós berendezés
WO2005034949A1 (en) * 2003-09-09 2005-04-21 University Of Florida Desferrithiocin derivatives and their use as iron chelators
US8034790B2 (en) * 2003-12-01 2011-10-11 Introgen Therapeutics Use of MDA-7 to inhibit pathogenic infectious organisms
US7815642B2 (en) * 2004-01-26 2010-10-19 Vidacare Corporation Impact-driven intraosseous needle
DE602005013355D1 (de) 2004-01-26 2009-04-30 Vidacare Corp Manuelle interossäre vorrichtung
EP1722842A1 (en) * 2004-01-26 2006-11-22 The Medical House Plc Needle-free injection device
US20070281041A1 (en) * 2004-03-02 2007-12-06 Introgen Therapeutics, Inc. Compositions and Methods Involving MDA-7 for the Treatment of Cancer
DE102004017970A1 (de) * 2004-04-12 2005-10-27 Leica Microsystems (Schweiz) Ag Stativ, insbesondere für Operationsmikroskope, mit einem Kraftspeicherelement
DE102004017971A1 (de) * 2004-04-12 2005-10-27 Leica Microsystems (Schweiz) Ag Stativ, insbesondere für Operationsmikroskope, mit einem Kraftspeicherelement
DE102005018305A1 (de) * 2004-05-25 2005-12-22 Tecpharma Licensing Ag Verabreichungsgerät mit geschütztem Primer
GB2414401B (en) 2004-05-28 2009-06-17 Cilag Ag Int Injection device
GB2414404B (en) 2004-05-28 2009-06-03 Cilag Ag Int Injection device
GB2414400B (en) * 2004-05-28 2009-01-14 Cilag Ag Int Injection device
GB2414399B (en) * 2004-05-28 2008-12-31 Cilag Ag Int Injection device
GB2414409B (en) * 2004-05-28 2009-11-18 Cilag Ag Int Injection device
GB2414402B (en) * 2004-05-28 2009-04-22 Cilag Ag Int Injection device
GB2414406B (en) 2004-05-28 2009-03-18 Cilag Ag Int Injection device
GB2414405B (en) * 2004-05-28 2009-01-14 Cilag Ag Int Injection device
US7717874B2 (en) * 2004-05-28 2010-05-18 Bioject, Inc. Needle-free injection system
GB2414403B (en) * 2004-05-28 2009-01-07 Cilag Ag Int Injection device
GB2414775B (en) * 2004-05-28 2008-05-21 Cilag Ag Int Releasable coupling and injection device
JP2008506447A (ja) 2004-07-14 2008-03-06 バイ−パス, インコーポレイテッド 材料送達システム
US7615041B2 (en) 2004-07-29 2009-11-10 Boston Scientific Scimed, Inc. Vial adaptor
JP4059238B2 (ja) * 2004-09-16 2008-03-12 ソニー株式会社 デジタル信号処理装置及びデジタル信号処理方法
ES2472441T3 (es) 2004-09-22 2014-07-01 Glaxosmithkline Biologicals S.A. Composición inmunog�nica para uso en vacunación contra estafilococos
US20060089594A1 (en) * 2004-10-26 2006-04-27 Sergio Landau Needle-free injection device
US20060089593A1 (en) * 2004-10-26 2006-04-27 Sergio Landau Needle-free injection device for individual users
US9492400B2 (en) * 2004-11-04 2016-11-15 Massachusetts Institute Of Technology Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
WO2006052655A2 (en) 2004-11-05 2006-05-18 Icu Medical, Inc. Soft-grip medical connector
US8998848B2 (en) * 2004-11-12 2015-04-07 Vidacare LLC Intraosseous device and methods for accessing bone marrow in the sternum and other target areas
CA2891057C (en) 2004-11-22 2018-11-13 Kaleo, Inc. Medicament delivery apparatus and movable indicator
WO2006058426A1 (en) * 2004-12-01 2006-06-08 Wlt Distributors Inc. Needle-free injector
BRPI0614025A2 (pt) 2005-01-24 2012-12-25 Antares Pharma Inc injetores de jato
CA2762072C (en) 2005-02-01 2017-08-29 Intelliject, Inc. Devices, systems, and methods for medicament delivery
GB2422784A (en) * 2005-02-07 2006-08-09 Caretek Medical Ltd Disposable assembly comprising a needle or stylet
CA2597329C (en) * 2005-02-08 2016-10-11 Board Of Regents, The University Of Texas System Compositions and methods involving mda-7 for the treatment of cancer
PT1861120T (pt) 2005-03-23 2016-08-18 Glaxosmithkline Biologicals Sa Utilização de um vírus influenza e de um adjuvante de emulsão óleo-em-água para induzir células t cd4 e/ou melhorar a resposta de células b de memória
AU2006232929B9 (en) 2005-04-04 2009-12-17 University Of Florida Research Foundation, Inc. Desferrithiocin polyether analogues
GB2424838B (en) * 2005-04-06 2011-02-23 Cilag Ag Int Injection device (adaptable drive)
GB2424836B (en) * 2005-04-06 2010-09-22 Cilag Ag Int Injection device (bayonet cap removal)
GB2425062B (en) * 2005-04-06 2010-07-21 Cilag Ag Int Injection device
GB2424837B (en) * 2005-04-06 2010-10-06 Cilag Ag Int Injection device
GB2427826B (en) * 2005-04-06 2010-08-25 Cilag Ag Int Injection device comprising a locking mechanism associated with integrally formed biasing means
GB2424835B (en) * 2005-04-06 2010-06-09 Cilag Ag Int Injection device (modified trigger)
US20070027428A1 (en) * 2005-05-03 2007-02-01 Pharmajet, Inc. Vial system and method for needle-less injector
US7699802B2 (en) * 2005-05-03 2010-04-20 Pharmajet, Inc. Needle-less injector
US7618393B2 (en) * 2005-05-03 2009-11-17 Pharmajet, Inc. Needle-less injector and method of fluid delivery
EP3441090A1 (en) 2005-05-17 2019-02-13 Amicus Therapeutics, Inc. A method for the treatment of pompe disease using 1-deoxynojirimycin and derivatives
WO2007016643A2 (en) * 2005-08-01 2007-02-08 Mount Sinai School Of Medicine Of New York University A method for extending longevity using npc1l1 antagonists
CA2616859C (en) 2005-08-03 2015-04-14 Fraunhofer Usa, Inc. Compositions and methods for production of immunoglobulins
US8591457B2 (en) * 2005-08-10 2013-11-26 Alza Corporation Method for making a needle-free jet injection drug delivery device
PL1759729T3 (pl) 2005-08-30 2010-09-30 Cilag Gmbh Int Zestaw igły do wstępnie napełnionego systemu strzykawki
US8980246B2 (en) 2005-09-07 2015-03-17 Sillajen Biotherapeutics, Inc. Oncolytic vaccinia virus cancer therapy
CA2621982C (en) 2005-09-07 2017-11-28 Jennerex Biotherapeutics Ulc Systemic treatment of metastatic and/or systemically-disseminated cancers using gm-csf-expressing poxviruses
US20110098656A1 (en) 2005-09-27 2011-04-28 Burnell Rosie L Auto-injection device with needle protecting cap having outer and inner sleeves
JP5219817B2 (ja) * 2005-10-13 2013-06-26 アルゴス・セラピューティクス・インコーポレーテッド 低温で貯蔵された液体薬剤の送達に適する装置、システム、および関連する方法
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
US9267937B2 (en) * 2005-12-15 2016-02-23 Massachusetts Institute Of Technology System for screening particles
DE102005062220B3 (de) * 2005-12-20 2007-02-15 Primojex Gmbh System zur Injektion durch oder in die menschliche Haut
EP1962947A4 (en) * 2005-12-20 2017-06-28 Antares Pharma, Inc. Needle-free injection device
GB0607088D0 (en) 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
AR058707A1 (es) 2005-12-22 2008-02-20 Glaxosmithkline Biolog Sa Vacuna, procedimiento para fabricarla y su uso
US20080161755A1 (en) * 2006-01-27 2008-07-03 Bioject Inc. Needle-free injection device and priming system
WO2007092944A2 (en) * 2006-02-08 2007-08-16 Introgen Therapeutics, Inc. Compositions and methods involving gene therapy and proteasome modulation
US20080279877A1 (en) * 2006-02-13 2008-11-13 Fraunhofer U.S.A. Inc. HPV antigens, vaccine compositions, and related methods
US8277816B2 (en) * 2006-02-13 2012-10-02 Fraunhofer Usa, Inc. Bacillus anthracis antigens, vaccine compositions, and related methods
JP2009526526A (ja) * 2006-02-13 2009-07-23 フラウンホーファー ユーエスエー, インコーポレイテッド インフルエンザ抗原、ワクチン組成物、および関連する方法
WO2007106415A2 (en) * 2006-03-10 2007-09-20 Massachusetts Institute Of Technology Triggered self-assembly conjugates and nanosystems
CA2681668C (en) 2006-03-23 2014-04-01 Michael S. Singer Compositions comprising prostaglandin f2-alpha analogs and methods for reducing body fat
JP2009531387A (ja) 2006-03-30 2009-09-03 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 免疫原性組成物
EP2007435B1 (en) * 2006-03-31 2019-12-18 Massachusetts Institute Of Technology System for targeted delivery of therapeutic agents
WO2007120638A2 (en) * 2006-04-12 2007-10-25 President And Fellows Of Harvard College Methods and compositions for modulating glycosylation
US8251947B2 (en) 2006-05-03 2012-08-28 Antares Pharma, Inc. Two-stage reconstituting injector
US9144648B2 (en) 2006-05-03 2015-09-29 Antares Pharma, Inc. Injector with adjustable dosing
CA2652280C (en) 2006-05-15 2014-01-28 Massachusetts Institute Of Technology Polymers for functional particles
WO2007137117A2 (en) * 2006-05-17 2007-11-29 Massachusetts Institute Of Technology Aptamer-directed drug delivery
GB2438593B (en) 2006-06-01 2011-03-30 Cilag Gmbh Int Injection device (cap removal feature)
GB2438591B (en) * 2006-06-01 2011-07-13 Cilag Gmbh Int Injection device
GB2438590B (en) 2006-06-01 2011-02-09 Cilag Gmbh Int Injection device
AU2007256780B2 (en) 2006-06-02 2013-08-29 President And Fellows Of Harvard College Protein surface remodeling
MX2008015462A (es) * 2006-06-07 2009-03-02 Acushot Inc Mecanismo de carga para un inyector libre de agua.
WO2007150030A2 (en) 2006-06-23 2007-12-27 Massachusetts Institute Of Technology Microfluidic synthesis of organic nanoparticles
US7824360B2 (en) * 2006-06-28 2010-11-02 Zion Azar Intradermal needles injection device
CN105727276A (zh) 2006-07-17 2016-07-06 葛兰素史密丝克莱恩生物有限公司 流感疫苗
WO2008021367A2 (en) * 2006-08-11 2008-02-21 President And Fellows Of Harvard College Moenomycin biosynthesis-related compositions and methods of use thereof
CA2660038A1 (en) * 2006-08-14 2008-06-19 Massachusetts Institute Of Technology Hemagglutinin polypeptides, and reagents and methods relating thereto
US20090269342A1 (en) * 2006-08-14 2009-10-29 Massachusetts Institute Of Technology Hemagglutinin Polypeptides, and Reagents and Methods Relating Thereto
US8944069B2 (en) 2006-09-12 2015-02-03 Vidacare Corporation Assemblies for coupling intraosseous (IO) devices to powered drivers
ES2612955T3 (es) 2006-09-12 2017-05-19 Vidacare LLC Dispositivos de aspiración de médula ósea
EP2073728B1 (en) 2006-09-12 2018-11-07 Teleflex Medical Devices S.à.r.l. Biopsy device
CN104656900A (zh) 2006-09-13 2015-05-27 意美森公司 用于游戏厅游戏触觉的系统和方法
CN102026645B (zh) 2006-09-15 2016-01-27 渥太华医院研究机构 溶瘤弹状病毒
US7547293B2 (en) * 2006-10-06 2009-06-16 Bioject, Inc. Triggering mechanism for needle-free injector
JO3598B1 (ar) 2006-10-10 2020-07-05 Infinity Discovery Inc الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
EA015817B1 (ru) 2006-10-12 2011-12-30 Глаксосмитклайн Байолоджикалс С.А. Иммуногенная композиция, содержащая адъювант в виде эмульсии "масло в воде"
EP2086582B1 (en) 2006-10-12 2012-11-14 GlaxoSmithKline Biologicals s.a. Vaccine comprising an oil in water emulsion adjuvant
US7780201B2 (en) * 2006-10-13 2010-08-24 Medela Holding Ag Tube connector with three part construction and latching component
ATE506985T1 (de) 2006-10-25 2011-05-15 Icu Medical Inc Medizinischer verbinder
US8974410B2 (en) 2006-10-30 2015-03-10 Vidacare LLC Apparatus and methods to communicate fluids and/or support intraosseous devices
US20100303723A1 (en) * 2006-11-20 2010-12-02 Massachusetts Institute Of Technology Drug delivery systems using fc fragments
AU2007329579A1 (en) 2006-12-01 2008-06-12 Anterios, Inc. Amphiphilic entity nanoparticles
EP2099496A2 (en) * 2006-12-08 2009-09-16 Massachusetts Institute of Technology Delivery of nanoparticles and/or agents to cells
US20080140001A1 (en) * 2006-12-12 2008-06-12 By-Pass Inc. Fluid Delivery Apparatus And Methods
TWI549692B (zh) 2006-12-26 2016-09-21 藍瑟斯醫學影像公司 使心臟神經分布顯像之配位體
PT2118123E (pt) 2007-01-31 2016-02-10 Harvard College Péptidos de p53 estabilizados e suas utilizações
WO2008098165A2 (en) * 2007-02-09 2008-08-14 Massachusetts Institute Of Technology Oscillating cell culture bioreactor
US8118814B2 (en) * 2007-02-14 2012-02-21 Depuy Mitek Inc. Implement for orientating a tool, particularly useful in surgical tools for harvesting and implanting bone plugs to repair damaged bone tissue
DE102007008597A1 (de) 2007-02-19 2008-08-21 Primojex Gmbh System zur Injektion eines Fluids durch oder in die menschliche Haut
WO2008103997A2 (en) * 2007-02-23 2008-08-28 Bioject Inc. Needle-free injection devices and drug delivery systems therefor
WO2008115433A1 (en) 2007-03-15 2008-09-25 University Of Florida Desferrithiocin polyether analogues
KR20080084528A (ko) 2007-03-15 2008-09-19 제네렉스 바이오테라퓨틱스 인크. 종양살상형 백시니아 바이러스 암 치료
US7960139B2 (en) 2007-03-23 2011-06-14 Academia Sinica Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
WO2008121767A2 (en) 2007-03-28 2008-10-09 President And Fellows Of Harvard College Stitched polypeptides
WO2008124463A2 (en) 2007-04-04 2008-10-16 Vidacare Corporation Powered drivers, intraosseous devices and methods to access bone marrow
WO2008124632A1 (en) 2007-04-04 2008-10-16 Massachusetts Institute Of Technology Amphiphilic compound assisted nanoparticles for targeted delivery
WO2008124634A1 (en) 2007-04-04 2008-10-16 Massachusetts Institute Of Technology Polymer-encapsulated reverse micelles
EP2152301A4 (en) * 2007-04-28 2010-07-28 Fraunhofer Usa Inc TRYPANOSOME ANTIGENS, VACCINE COMPOSITIONS AND RELATED METHODS
US20100191215A1 (en) * 2007-06-12 2010-07-29 By-Pass ,Inc. Pressure pulse actuating device for delivery systems
EA020953B1 (ru) * 2007-06-14 2015-03-31 Краселл Свитзерленд Аг Внутрикожная вакцина против гриппа
WO2008156676A1 (en) 2007-06-15 2008-12-24 President And Fellows Of Harvard College Methods and compositions for detecting and modulating o-glycosylation
EA200901578A1 (ru) 2007-06-26 2010-08-30 Глаксосмитклайн Байолоджикалс С.А. Вакцина, содержащая конъюгаты капсульных полисахаридов streptococcus pneumoniae
US8404252B2 (en) 2007-07-11 2013-03-26 Fraunhofer Usa, Inc. Yersinia pestis antigens, vaccine compositions, and related methods
US20110059130A1 (en) * 2007-08-20 2011-03-10 Fraunhofer Usa, Inc. Prophylactic and therapeutic influenza vaccines, antigens, compositions and methods
CA2704933A1 (en) 2007-08-21 2009-02-26 Yukon Medical, Llc Vial access and injection system
US8604004B2 (en) * 2007-10-04 2013-12-10 President And Fellows Of Harvard College Moenomycin analogs, methods of synthesis, and uses thereof
US8172797B2 (en) * 2007-10-10 2012-05-08 Shl Group Ab Medical delivery device
JP2011500569A (ja) 2007-10-12 2011-01-06 マサチューセッツ インスティテュート オブ テクノロジー ワクチンナノテクノロジー
EP2231258A1 (en) * 2007-12-21 2010-09-29 Aesthetic Sciences Corporation Self-contained pressurized injection device
US8815522B2 (en) * 2008-01-03 2014-08-26 Massachusetts Institute Of Technology Decoy influenza therapies
US8193182B2 (en) 2008-01-04 2012-06-05 Intellikine, Inc. Substituted isoquinolin-1(2H)-ones, and methods of use thereof
DE102008008023A1 (de) 2008-02-04 2009-08-13 Primojex Gmbh System zur Injektion eines Fluids durch oder in die menschlische Haut
US9486292B2 (en) 2008-02-14 2016-11-08 Immersion Corporation Systems and methods for real-time winding analysis for knot detection
WO2009111794A1 (en) * 2008-03-07 2009-09-11 Pharmajet, Inc. Intradermal injector and uses thereof
EP2268342B1 (en) 2008-03-10 2015-09-16 Antares Pharma, Inc. Injector safety device
US9117870B2 (en) * 2008-03-27 2015-08-25 Lam Research Corporation High throughput cleaner chamber
US8936571B2 (en) * 2008-03-31 2015-01-20 Laura Devega Illuminated syringe
JP5685522B2 (ja) * 2008-04-01 2015-03-18 ユーコン・メディカル,リミテッド・ライアビリティ・カンパニー 複式容器用流体移送装置
TW201000107A (en) * 2008-04-09 2010-01-01 Infinity Pharmaceuticals Inc Inhibitors of fatty acid amide hydrolase
WO2009127676A1 (en) 2008-04-16 2009-10-22 Glaxosmithkline Biologicals S.A. Vaccine
WO2009134808A2 (en) * 2008-04-28 2009-11-05 President And Fellows Of Harvard College Supercharged proteins for cell penetration
US8177749B2 (en) 2008-05-20 2012-05-15 Avant Medical Corp. Cassette for a hidden injection needle
JP5836120B2 (ja) 2008-05-20 2015-12-24 アヴァント・メディカル・コーポレーション オートインジェクタシステム
US8052645B2 (en) 2008-07-23 2011-11-08 Avant Medical Corp. System and method for an injection using a syringe needle
GB2461086B (en) * 2008-06-19 2012-12-05 Cilag Gmbh Int Injection device
GB2461089B (en) * 2008-06-19 2012-09-19 Cilag Gmbh Int Injection device
GB2461085B (en) * 2008-06-19 2012-08-29 Cilag Gmbh Int Injection device
GB2461087B (en) * 2008-06-19 2012-09-26 Cilag Gmbh Int Injection device
GB2461084B (en) * 2008-06-19 2012-09-26 Cilag Gmbh Int Fluid transfer assembly
GB2461088B (en) * 2008-06-19 2012-09-26 Cilag Gmbh Int Injection device
BRPI0914630A2 (pt) 2008-06-26 2019-09-24 Anterios Inc liberação dérmica
ES2442024T3 (es) 2008-07-15 2014-02-07 Academia Sinica Matrices de glucano sobre portaobjetos de vidrio revestidos con aluminio de tipo PTFE y métodos relacionados
WO2010011313A2 (en) 2008-07-23 2010-01-28 President And Fellows Of Harvard College Ligation of stapled polypeptides
US20100075926A1 (en) * 2008-07-23 2010-03-25 Li-Huei Tsai Activation of histone deacetylase 1 (hdac1) protects against dna damage and increases neuronal survival
US20100021472A1 (en) * 2008-07-25 2010-01-28 Geetha Srikrishna Methods for diagnosing and treating cancer
JP5611208B2 (ja) 2008-08-05 2014-10-22 アンタレス・ファーマ・インコーポレーテッド 多数回服用量の注射装置
WO2010037046A1 (en) 2008-09-28 2010-04-01 Fraunhofer Usa, Inc. Humanized neuraminidase antibody and methods of use thereof
US8277812B2 (en) * 2008-10-12 2012-10-02 Massachusetts Institute Of Technology Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
US8343497B2 (en) 2008-10-12 2013-01-01 The Brigham And Women's Hospital, Inc. Targeting of antigen presenting cells with immunonanotherapeutics
US8591905B2 (en) * 2008-10-12 2013-11-26 The Brigham And Women's Hospital, Inc. Nicotine immunonanotherapeutics
US8343498B2 (en) 2008-10-12 2013-01-01 Massachusetts Institute Of Technology Adjuvant incorporation in immunonanotherapeutics
CA2743904A1 (en) 2008-11-17 2010-05-20 The Regents Of The University Of Michigan Cancer vaccine compositions and methods of using the same
US9637746B2 (en) 2008-12-15 2017-05-02 Greenlight Biosciences, Inc. Methods for control of flux in metabolic pathways
CN105132387A (zh) * 2008-12-22 2015-12-09 绿光生物科学公司 用于制造化合物的组合物和方法
AU2010226442A1 (en) 2009-03-20 2011-10-13 Antares Pharma, Inc. Hazardous agent injection system
US8454579B2 (en) 2009-03-25 2013-06-04 Icu Medical, Inc. Medical connector with automatic valves and volume regulator
US20100252373A1 (en) * 2009-04-02 2010-10-07 Innovative Office Products, Inc. Friction device for a spring cylinder
WO2010118159A1 (en) 2009-04-07 2010-10-14 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
WO2010118155A1 (en) 2009-04-07 2010-10-14 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
US8940766B2 (en) 2009-04-09 2015-01-27 Amicus Therapeutics, Inc. Methods for preventing and/or treating lysosomal storage disorders
US9345640B2 (en) 2009-04-14 2016-05-24 Yukon Medical, Llc Fluid transfer device
JP2012525146A (ja) 2009-04-28 2012-10-22 プレジデント アンド フェロウズ オブ ハーバード カレッジ 細胞透過のための過剰に荷電されたタンパク質
US8927551B2 (en) * 2009-05-18 2015-01-06 Infinity Pharmaceuticals, Inc. Isoxazolines as inhibitors of fatty acid amide hydrolase
US9149465B2 (en) * 2009-05-18 2015-10-06 Infinity Pharmaceuticals, Inc. Isoxazolines as inhibitors of fatty acid amide hydrolase
US8765735B2 (en) * 2009-05-18 2014-07-01 Infinity Pharmaceuticals, Inc. Isoxazolines as inhibitors of fatty acid amide hydrolase
US9104791B2 (en) 2009-05-28 2015-08-11 Immersion Corporation Systems and methods for editing a model of a physical system for a simulation
EP2438046A4 (en) 2009-06-01 2013-04-17 Harvard College O-GLCNAC TRANSFERASE INHIBITORS AND USES THEREOF
CA2768299C (en) 2009-07-13 2018-03-20 President And Fellows Of Harvard College Bifunctional stapled polypeptides and uses thereof
GB0913681D0 (en) 2009-08-05 2009-09-16 Glaxosmithkline Biolog Sa Immunogenic composition
ES2848650T3 (es) 2009-09-14 2021-08-11 Sillajen Biotherapeutics Inc Terapia combinada contra el cáncer con virus vaccinia oncolítico
JP2013505300A (ja) 2009-09-22 2013-02-14 エルロン・セラピューティクス・インコーポレイテッド ペプチド模倣大環状分子
WO2011041391A1 (en) 2009-09-29 2011-04-07 Fraunhofer Usa, Inc. Influenza hemagglutinin antibodies, compositions, and related methods
BR112012009123A2 (pt) 2009-10-19 2017-09-19 Amicus Therapeutics Inc novas composições para a prevenção e/ou tratamento de distúrbios de depósito lisossômico
ES2617192T3 (es) 2009-10-19 2017-06-15 Amicus Therapeutics, Inc. Nuevas composiciones para prevenir y/o tratar trastornos degenerativos del sistema nervioso central
US10087236B2 (en) 2009-12-02 2018-10-02 Academia Sinica Methods for modifying human antibodies by glycan engineering
US11377485B2 (en) 2009-12-02 2022-07-05 Academia Sinica Methods for modifying human antibodies by glycan engineering
AU2010329551B2 (en) 2009-12-10 2016-02-11 Turnstone Limited Partnership Oncolytic rhabdovirus
EP2519517B1 (en) 2009-12-29 2015-03-25 Dana-Farber Cancer Institute, Inc. Type ii raf kinase inhibitors
JP6210685B2 (ja) 2010-01-27 2017-10-11 マサチューセッツ インスティテュート オブ テクノロジー 標的化された広域スペクトルのインフルエンザ中和のための操作されたポリペプチド剤
CN102834401B (zh) * 2010-02-03 2016-08-24 无限药品股份有限公司 脂肪酸酰胺水解酶抑制剂
EP3338770B1 (en) 2010-03-08 2023-06-07 Sloan-Kettering Institute For Cancer Research Cdc7 kinase inhibitors and uses thereof
GB201003920D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Method of treatment
GB201003922D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Conjugation process
EP2550285B1 (en) 2010-03-22 2017-07-19 President and Fellows of Harvard College Trioxacarcins and uses thereof
USD644731S1 (en) 2010-03-23 2011-09-06 Icu Medical, Inc. Medical connector
WO2011130332A1 (en) 2010-04-12 2011-10-20 Academia Sinica Glycan arrays for high throughput screening of viruses
WO2011140296A1 (en) 2010-05-05 2011-11-10 Infinity Pharmaceuticals Triazoles as inhibitors of fatty acid synthase
EP2566853B1 (en) 2010-05-05 2017-01-25 Infinity Pharmaceuticals, Inc. Tetrazolones as inhibitors of fatty acid synthase
EP2566953B1 (en) 2010-05-07 2019-01-02 Greenlight Biosciences, Inc. Methods for control of flux in metabolic pathways through enzyme relocation
KR102136503B1 (ko) 2010-05-11 2020-07-21 랜티우스 메디컬 이메징, 인크. 영상화제의 합성 및 사용을 위한 조성물, 방법 및 시스템
US8758306B2 (en) 2010-05-17 2014-06-24 Icu Medical, Inc. Medical connectors and methods of use
USD655017S1 (en) 2010-06-17 2012-02-28 Yukon Medical, Llc Shroud
WO2011160042A2 (en) 2010-06-18 2011-12-22 Makoto Life Sciences, Inc. Prpk-tprkb modulators and uses thereof
EP2600901B1 (en) 2010-08-06 2019-03-27 ModernaTX, Inc. A pharmaceutical formulation comprising engineered nucleic acids and medical use thereof
RU2582678C2 (ru) 2010-08-13 2016-04-27 Эйлерон Терапьютикс, Инк. Пептидомиметические макроциклы
WO2012030980A1 (en) 2010-08-31 2012-03-08 Greenlight Biosciences, Inc. Methods for control of flux in metabolic pathways through protease manipulation
AU2011305371B2 (en) 2010-09-21 2015-05-21 Massachusetts Institute Of Technology Human-adapted HA polypeptides, vaccines, and influenza treatment
US8957026B2 (en) 2010-09-22 2015-02-17 President And Fellows Of Harvard College Beta-catenin targeting peptides and uses thereof
ES2737960T3 (es) 2010-10-01 2020-01-17 Modernatx Inc Nucleósidos, nucleótidos y ácidos nucleicos modificados y sus usos
CN103328002B (zh) 2010-10-04 2020-01-14 麻省理工学院 血球凝集素多肽以及与其相关的试剂和方法
WO2012064973A2 (en) 2010-11-10 2012-05-18 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
CN103200980B (zh) * 2010-11-19 2016-03-16 Msd消费保健品公司 点按笔敷料器装置及其使用方法
KR101224581B1 (ko) 2010-12-10 2013-01-21 주식회사 모리스 튜브 용기의 자동 밀폐 구조형 마개
GB201021716D0 (en) * 2010-12-22 2011-02-02 Owen Mumford Ltd Autoinjectors
CN103429258B (zh) 2011-01-04 2016-03-09 新罗杰公司 通过施用溶瘤痘苗病毒生成针对肿瘤抗原的抗体和生成肿瘤特异性补体依赖性细胞毒性
CN103648499B (zh) 2011-01-10 2017-02-15 无限药品股份有限公司 用于制备异喹啉酮的方法及异喹啉酮的固体形式
CA2822908A1 (en) * 2011-01-10 2012-07-19 Zogenix, Inc. Improved needle free injectors
EP3378480A1 (en) 2011-01-19 2018-09-26 Topokine Therapeutics, Inc. Methods and compositions for treating obesity
KR20140005998A (ko) 2011-01-24 2014-01-15 안테리오스, 인코퍼레이티드 나노입자 조성물, 이의 제형, 및 그의 용도
KR20140003572A (ko) 2011-01-24 2014-01-09 안테리오스, 인코퍼레이티드 나노입자 조성물
EP2667945A1 (en) 2011-01-24 2013-12-04 Anterios, Inc. Oil compositions
KR20140010126A (ko) 2011-03-03 2014-01-23 터서스 파마수티칼 엘엘씨 C16:1n7-팔미톨리에이트를 포함하는 조성물들 및 방법들
GB201103836D0 (en) 2011-03-07 2011-04-20 Glaxosmithkline Biolog Sa Conjugation process
WO2012135615A2 (en) 2011-03-30 2012-10-04 Brown University Enopeptins, uses thereof, and methods of synthesis thereto
AU2012236099A1 (en) 2011-03-31 2013-10-03 Moderna Therapeutics, Inc. Delivery and formulation of engineered nucleic acids
KR102036933B1 (ko) * 2011-04-04 2019-10-25 이데 인터내셔널 알앤디 인코퍼레이션 바늘이 없는 분사기 윈드 조립체
WO2012145554A2 (en) * 2011-04-19 2012-10-26 Invisiderm, Llc Method of producing substances with supersaturated gas,transdermal delivery device thereof, and uses thereof
JP6038884B2 (ja) 2011-04-20 2016-12-07 アムゲン・インコーポレーテッド 自動式注射装置
AR086405A1 (es) 2011-05-17 2013-12-11 Glaxosmithkline Biolog Sa Vacuna de streptococcus pneumoniae
WO2012167382A1 (en) 2011-06-08 2012-12-13 Children's Hospital Of Eastern Ontario Research Institute Inc. Compositions and methods for glioblastoma treatment
AU2012272815B2 (en) 2011-06-22 2017-09-07 The General Hospital Corporation Treatment of proteinopathies
US9220660B2 (en) 2011-07-15 2015-12-29 Antares Pharma, Inc. Liquid-transfer adapter beveled spike
US8496619B2 (en) 2011-07-15 2013-07-30 Antares Pharma, Inc. Injection device with cammed ram assembly
CA2842190A1 (en) 2011-07-19 2013-01-24 Infinity Pharmaceuticals Inc. Heterocyclic compounds and uses thereof
EP2734520B1 (en) 2011-07-19 2016-09-14 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
TR201901856T4 (tr) 2011-07-22 2019-03-21 Massachusetts Inst Technology Sınıf I histon deasetilazların (HDAC'ler) aktivatörleri ve kullanımları.
US9408972B2 (en) 2011-08-02 2016-08-09 Pharmajet, Inc. Needle-free injection device
WO2013032591A1 (en) 2011-08-29 2013-03-07 Infinity Pharmaceuticals Inc. Heterocyclic compounds and uses thereof
USD681230S1 (en) 2011-09-08 2013-04-30 Yukon Medical, Llc Shroud
BR122019017259B1 (pt) 2011-09-09 2022-05-10 Lantheus Medical Imaging, Inc Compostos úteis como agentes de imageamento, composições que os compreende, métodos, e uso de agentes de imageamento
EP2753702B1 (en) 2011-09-09 2021-12-15 GreenLight Biosciences, Inc. Cell-free preparation of carbapenems
EP3384938A1 (en) 2011-09-12 2018-10-10 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
US9630979B2 (en) 2011-09-29 2017-04-25 Infinity Pharmaceuticals, Inc. Inhibitors of monoacylglycerol lipase and methods of their use
EP3682905B1 (en) 2011-10-03 2021-12-01 ModernaTX, Inc. Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
US20130096170A1 (en) 2011-10-14 2013-04-18 Hospira, Inc. Methods of treating pediatric patients using dexmedetomidine
TWI643868B (zh) 2011-10-18 2018-12-11 艾利倫治療公司 擬肽巨環化合物
EP2822935B1 (en) 2011-11-17 2019-05-15 Dana-Farber Cancer Institute, Inc. Inhibitors of c-jun-n-terminal kinase (jnk)
GB201119999D0 (en) 2011-11-20 2012-01-04 Glaxosmithkline Biolog Sa Vaccine
GB201120000D0 (en) 2011-11-20 2012-01-04 Glaxosmithkline Biolog Sa Vaccine
KR102102176B1 (ko) 2011-12-13 2020-04-21 파마젯 인코포레이티드 니들 프리 피내 주입 장치
EP2791160B1 (en) 2011-12-16 2022-03-02 ModernaTX, Inc. Modified mrna compositions
ES2761200T3 (es) 2011-12-16 2020-05-19 Univ Florida Usos de análogos de 4'-desferritiocina
US8426471B1 (en) 2011-12-19 2013-04-23 Topokine Therapeutics, Inc. Methods and compositions for reducing body fat and adipocytes
US8242158B1 (en) 2012-01-04 2012-08-14 Hospira, Inc. Dexmedetomidine premix formulation
US10130800B2 (en) 2012-01-27 2018-11-20 Invisiderm, Llc Method of producing substances with supersaturated gas, transdermal delivery device thereof, and uses thereof
JP6450191B2 (ja) 2012-02-15 2019-01-09 エイルロン セラピューティクス,インコーポレイテッド ペプチドミメティック大環状化合物
EP2819688A4 (en) 2012-02-15 2015-10-28 Aileron Therapeutics Inc TRIAZOL AND THIOETHER-COUPLED PEPTIDOMIMETIC MACROCYCLES
JP6165786B2 (ja) 2012-03-06 2017-07-19 アンタレス・ファーマ・インコーポレーテッド 離脱力特徴を備える充填シリンジ
US20150090741A1 (en) * 2012-03-23 2015-04-02 Ddps Global, Llc Compression Spring and Pump for Dispensing Fluid
US9464050B2 (en) 2012-03-27 2016-10-11 Amicus Therapeutics, Inc. Compounds for preventing and/or treating lysosomal storage disorders and/or degenerative disorders of the central nervous system
US9273084B2 (en) 2012-04-06 2016-03-01 President And Fellows Of Harvard College Moenomycin analogs, methods of synthesis, and uses thereof
US10106833B2 (en) 2012-04-06 2018-10-23 President And Fellows Of Harvard College Methods and compounds for identifying glycosyltransferase inhibitors
CN104487114A (zh) 2012-04-06 2015-04-01 安塔雷斯药品公司 针头辅助喷射注射给予睾酮组合物
US9902985B2 (en) 2012-04-06 2018-02-27 President And Fellows Of Harvard College Chemoenzymatic methods for synthesizing moenomycin analogs
US8940742B2 (en) 2012-04-10 2015-01-27 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
US10130714B2 (en) 2012-04-14 2018-11-20 Academia Sinica Enhanced anti-influenza agents conjugated with anti-inflammatory activity
USD808010S1 (en) 2012-04-20 2018-01-16 Amgen Inc. Injection device
USD898908S1 (en) 2012-04-20 2020-10-13 Amgen Inc. Pharmaceutical product cassette for an injection device
EP2841098A4 (en) 2012-04-23 2016-03-02 Allertein Therapeutics Llc NANOPARTICLES FOR THE TREATMENT OF ALLERGIES
WO2013169800A1 (en) 2012-05-07 2013-11-14 Antares Pharma, Inc. Injection device with cammed ram assembly
CA2871160C (en) 2012-05-10 2023-03-14 Massachusetts Institute Of Technology Agents for influenza neutralization
USD769444S1 (en) 2012-06-28 2016-10-18 Yukon Medical, Llc Adapter device
UA114108C2 (uk) 2012-07-10 2017-04-25 Борд Оф Ріджентс, Дзе Юніверсіті Оф Техас Сістем Моноклональне антитіло для застосування в діагностиці і терапії злоякісних пухлин і аутоімунного захворювання
JP2015521949A (ja) * 2012-07-12 2015-08-03 アンタレス・ファーマ・インコーポレーテッド 液体移送アダプタの面取りしたスパイク
JP2015525794A (ja) 2012-08-06 2015-09-07 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 乳児においてrsv及び百日咳菌に対する免疫応答を惹起するための方法
US20140037680A1 (en) 2012-08-06 2014-02-06 Glaxosmithkline Biologicals, S.A. Novel method
AU2013203000B9 (en) 2012-08-10 2017-02-02 Lantheus Medical Imaging, Inc. Compositions, methods, and systems for the synthesis and use of imaging agents
US9914956B2 (en) 2012-08-18 2018-03-13 Academia Sinica Cell-permeable probes for identification and imaging of sialidases
RS61957B1 (sr) 2012-09-26 2021-07-30 Harvard College Uvezani peptidi blokirani prolinom i njihove upotrebe
WO2014055564A1 (en) 2012-10-01 2014-04-10 President And Fellows Of Harvard College Stabilized polypeptide insulin receptor modulators
ES2719776T3 (es) 2012-10-12 2019-07-16 Broad Inst Inc Inhibidores de GSK3 y métodos de uso de los mismos
EP2909194A1 (en) 2012-10-18 2015-08-26 Dana-Farber Cancer Institute, Inc. Inhibitors of cyclin-dependent kinase 7 (cdk7)
US10000483B2 (en) 2012-10-19 2018-06-19 Dana-Farber Cancer Institute, Inc. Bone marrow on X chromosome kinase (BMX) inhibitors and uses thereof
WO2014063061A1 (en) 2012-10-19 2014-04-24 Dana-Farber Cancer Institute, Inc. Hydrophobically tagged small molecules as inducers of protein degradation
WO2014071241A1 (en) 2012-11-01 2014-05-08 Aileron Therapeutics, Inc. Disubstituted amino acids and methods of preparation and use thereof
ES2691742T5 (es) 2012-11-01 2022-03-18 Infinity Pharmaceuticals Inc Tratamiento de cánceres utilizando moduladores de isoformas de PI3 cinasa
WO2014071247A1 (en) 2012-11-02 2014-05-08 Dana-Farber Cancer Institute, Inc. Pyrrol-1 -yl benzoic acid derivates useful as myc inhibitors
CA2869676C (en) 2012-11-21 2015-06-23 Topokine Therapeutics, Inc. Uses and compositions comprising a thiazolidinedione and oleic acid for locally increasing subcutaneous fat
EP4074834A1 (en) 2012-11-26 2022-10-19 ModernaTX, Inc. Terminally modified rna
JP6408478B2 (ja) 2012-11-26 2018-10-17 プレジデント アンド フェローズ オブ ハーバード カレッジ トリオキサカルシン、トリオキサカルシン−抗体複合体、およびその用途
WO2014100695A1 (en) 2012-12-21 2014-06-26 Epizyme, Inc. Prmt5 inhibitors and uses thereof
US9611257B2 (en) 2012-12-21 2017-04-04 Epizyme, Inc. PRMT5 inhibitors and uses thereof
HUE040323T2 (hu) 2012-12-21 2019-02-28 Epizyme Inc PRMT5-inhibitorok és alkalmazásaik
EP2935243B1 (en) 2012-12-21 2018-03-14 Epizyme, Inc. Prmt5 inhibitors containing a dihydro- or tetrahydroisoquinoline and uses thereof
EP2946014A2 (en) 2013-01-17 2015-11-25 Moderna Therapeutics, Inc. Signal-sensor polynucleotides for the alteration of cellular phenotypes
EP2953967B1 (en) 2013-02-07 2019-05-01 Massachusetts Institute of Technology Human adaptation of h5 influenza
US11576958B2 (en) 2013-02-07 2023-02-14 Children's Medical Center Corporation Protein antigens that provide protection against pneumococcal colonization and/or disease
EP2953667B1 (en) 2013-02-11 2019-10-23 Antares Pharma, Inc. Needle assisted jet injection device having reduced trigger force
RU2684211C2 (ru) 2013-02-21 2019-04-04 Тёрнстоун Лимитед Партнершип Композиция вакцины
WO2014164786A1 (en) 2013-03-11 2014-10-09 Madsen Patrick Dosage injector with pinion system
WO2014165136A1 (en) 2013-03-12 2014-10-09 Antares Pharma, Inc. Constant volume prefilled syringes and kits thereof
WO2014159813A1 (en) 2013-03-13 2014-10-02 Moderna Therapeutics, Inc. Long-lived polynucleotide molecules
CA2909620A1 (en) 2013-03-13 2014-10-02 President And Fellows Of Harvard College Stapled and stitched polypeptides and uses thereof
US9866924B2 (en) 2013-03-14 2018-01-09 Immersion Corporation Systems and methods for enhanced television interaction
JP6336564B2 (ja) 2013-03-15 2018-06-06 アムゲン・インコーポレーテッド 薬物カセット、自動注入器、および自動注入器システム
JP6768501B2 (ja) 2013-03-15 2020-10-14 アムゲン・インコーポレーテッド 薬物カセット、自動注入機、および自動注入機システム
NZ629037A (en) 2013-03-15 2017-04-28 Infinity Pharmaceuticals Inc Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
MX2015013894A (es) 2013-04-03 2015-12-11 Allertein Therapeutics Llc Composiciones de nanoparticulas novedosas.
CA3130061A1 (en) 2013-04-04 2014-10-09 President And Fellows Of Harvard College Macrolides and methods of their preparation and use
WO2014169073A1 (en) 2013-04-09 2014-10-16 Massachusetts Institute Of Technology Drug delivery polymer and uses thereof
WO2014179464A1 (en) 2013-04-30 2014-11-06 Massachusetts Institute Of Technology Human adaptation of h3 influenza
US9315472B2 (en) 2013-05-01 2016-04-19 Massachusetts Institute Of Technology 1,3,5-triazinane-2,4,6-trione derivatives and uses thereof
NO2753788T3 (zh) 2013-05-10 2018-06-16
US20160113932A1 (en) 2013-05-30 2016-04-28 Infinity Pharmaceuticals, Inc. Treatment of cancers using pi3 kinase isoform modulators
WO2014197723A2 (en) 2013-06-05 2014-12-11 Massachusetts Institute Of Technology Human adaptation of h7 ha
JP6469661B2 (ja) 2013-06-11 2019-02-13 カラ ファーマシューティカルズ インコーポレイテッド 尿素誘導体及びその使用
GB2515039B (en) 2013-06-11 2015-05-27 Cilag Gmbh Int Injection Device
GB2515038A (en) 2013-06-11 2014-12-17 Cilag Gmbh Int Injection device
GB2517896B (en) 2013-06-11 2015-07-08 Cilag Gmbh Int Injection device
GB2515032A (en) 2013-06-11 2014-12-17 Cilag Gmbh Int Guide for an injection device
EP3008081B1 (en) 2013-06-14 2017-08-30 President and Fellows of Harvard College Stabilized polypeptide insulin receptor modulators
EP3013365B1 (en) 2013-06-26 2019-06-05 Academia Sinica Rm2 antigens and use thereof
WO2014210564A1 (en) 2013-06-27 2014-12-31 Academia Sinica Glycan conjugates and use thereof
WO2015013635A2 (en) 2013-07-25 2015-01-29 Dana-Farber Cancer Institute, Inc. Inhibitors of transcription factors and uses thereof
DK3030671T3 (en) 2013-08-05 2019-01-21 Greenlight Biosciences Inc MODIFIED PROTEINS WITH A PROTEASE CLEANING PLACE
EP3492097A1 (en) 2013-08-05 2019-06-05 GlaxoSmithKline Biologicals S.A. Combination immunogenic compositions
CA2923579C (en) 2013-09-06 2023-09-05 Academia Sinica Human inkt cell activation using glycolipids with altered glycosyl groups
CA2925944C (en) 2013-10-04 2023-01-10 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
WO2015051241A1 (en) 2013-10-04 2015-04-09 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
US9265881B2 (en) * 2013-10-14 2016-02-23 Medtronic Minimed, Inc. Therapeutic agent injection device
WO2015057894A1 (en) 2013-10-15 2015-04-23 Massachusetts Institute Of Technology Methods for treating polycystic kidney disease and polycystic liver disease
WO2015057958A2 (en) 2013-10-16 2015-04-23 Massachusetts Institute Of Technology Enterobactin conjugates and uses thereof
EP3057956B1 (en) 2013-10-18 2021-05-05 Dana-Farber Cancer Institute, Inc. Polycyclic inhibitors of cyclin-dependent kinase 7 (cdk7)
US20160264551A1 (en) 2013-10-18 2016-09-15 Syros Pharmaceuticals, Inc. Heteroaromatic compounds useful for the treatment of prolferative diseases
WO2015061204A1 (en) 2013-10-21 2015-04-30 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
AU2014342042B2 (en) 2013-11-01 2017-08-17 KALA BIO, Inc. Crystalline forms of therapeutic compounds and uses thereof
CA2932124C (en) 2013-12-11 2023-05-09 Icu Medical, Inc. Check valve
JP6494631B2 (ja) 2013-12-24 2019-04-03 プレジデント アンド フェローズ オブ ハーバード カレッジ コルチスタチン類縁体並びにその合成及び使用
US10150818B2 (en) 2014-01-16 2018-12-11 Academia Sinica Compositions and methods for treatment and detection of cancers
AU2015206370A1 (en) 2014-01-16 2016-07-07 Academia Sinica Compositions and methods for treatment and detection of cancers
WO2015117087A1 (en) 2014-01-31 2015-08-06 Dana-Farber Cancer Institute, Inc. Uses of diazepane derivatives
TW201613861A (en) 2014-02-12 2016-04-16 Amicus Therapeutics Inc Sugar derivatives comprising sulfur-containing moieties and methods of making same and methods of using the same for the treatment of MPS IIIC
US10287334B2 (en) 2014-03-07 2019-05-14 The Arizona Board Of Regents On Behalf Of The University Of Arizona Non-narcotic CRMP2 peptides targeting sodium channels for chronic pain
EP4066834A1 (en) 2014-03-19 2022-10-05 Infinity Pharmaceuticals, Inc. Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders
CN106415244B (zh) 2014-03-27 2020-04-24 中央研究院 反应性标记化合物及其用途
US10293035B2 (en) 2014-03-28 2019-05-21 University Of Washington Through Its Center For Commercialization Breast and ovarian cancer vaccines
US9675627B2 (en) 2014-04-14 2017-06-13 Amicus Therapeutics, Inc. Dosing regimens for treating and/or preventing cerebral amyloidoses
WO2015164604A1 (en) 2014-04-23 2015-10-29 Dana-Farber Cancer Institute, Inc. Hydrophobically tagged janus kinase inhibitors and uses thereof
WO2015164614A1 (en) 2014-04-23 2015-10-29 Dana-Farber Cancer Institute, Inc. Janus kinase inhibitors and uses thereof
WO2015168079A1 (en) 2014-04-29 2015-11-05 Infinity Pharmaceuticals, Inc. Pyrimidine or pyridine derivatives useful as pi3k inhibitors
WO2015168380A1 (en) 2014-04-30 2015-11-05 Massachusetts Institute Of Technology Siderophore-based immunization against gram-negative bacteria
US10195113B2 (en) 2014-04-30 2019-02-05 Massachusetts Institute Of Technology Adaptor for removal of fluid from vial using a needle-free syringe
JP6759109B2 (ja) 2014-05-21 2020-09-23 プレジデント アンド フェローズ オブ ハーバード カレッジ Ras抑制性ペプチドおよびその使用
EP3149037A4 (en) 2014-05-27 2018-01-10 Academia Sinica Anti-her2 glycoantibodies and uses thereof
US10118969B2 (en) 2014-05-27 2018-11-06 Academia Sinica Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
KR20230033737A (ko) 2014-05-27 2023-03-08 아카데미아 시니카 증진된 항체 효능을 위한 범용 당형태에 관한 조성물 및 방법
KR20220151036A (ko) 2014-05-27 2022-11-11 아카데미아 시니카 항-cd20 글리코항체 및 이의 용도
KR102494193B1 (ko) 2014-05-28 2023-01-31 아카데미아 시니카 항-tnf-알파 글리코항체 및 이의 용도
EP3888676A1 (en) 2014-06-13 2021-10-06 GlaxoSmithKline Biologicals S.A. Immunogenic combinations
BR112016029662B1 (pt) 2014-06-19 2023-10-24 Takeda Pharmaceutical Company Limited COMPOSTO DE FÓRMULA Bf OU UMA FORMA FARMACEUTICAMENTE ACEITÁVEL DO MESMO, COMPOSIÇÃO FARMACÊUTICA COMPREENDENDO O MESMO E SEU USO
US10188661B2 (en) 2014-06-27 2019-01-29 Topokine Therapeutics, Inc. Topical dosage regimen
WO2016004202A1 (en) 2014-07-02 2016-01-07 Massachusetts Institute Of Technology Polyamine-fatty acid derived lipidoids and uses thereof
EP3169699A4 (en) 2014-07-18 2018-06-20 The University of Washington Cancer vaccine compositions and methods of use thereof
WO2016025327A1 (en) 2014-08-10 2016-02-18 Antares Pharma, Inc. A syringe shock absorber for use in an injection device
US10736966B2 (en) 2014-08-12 2020-08-11 Massachusetts Institute Of Technology Brush-poly (glycoamidoamine)-lipids and uses thereof
CN204033941U (zh) * 2014-08-27 2014-12-24 北京快舒尔医疗技术有限公司 一种具有电动功能的无针注射器
WO2016040369A2 (en) 2014-09-08 2016-03-17 Academia Sinica HUMAN iNKT CELL ACTIVATION USING GLYCOLIPIDS
KR20170058424A (ko) 2014-09-24 2017-05-26 에일러론 테라퓨틱스 인코포레이티드 펩티드모방 거대고리 및 이의 용도
KR102570210B1 (ko) 2014-09-24 2023-08-23 에일러론 테라퓨틱스 인코포레이티드 펩티드모방 거대고리 및 이의 제제
WO2016054491A1 (en) 2014-10-03 2016-04-07 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
MX2017005120A (es) 2014-10-21 2018-02-12 Ariad Pharma Inc Formas cristalinas de 5-cloro-n4-[-2-(dimetilfosforil) fenil]-n2-{2-metoxi-4-[4-(4-metilpiperazin-1-il)piperidin-1-il] pirimidin-2,4-diamina.
JP2017533238A (ja) 2014-10-28 2017-11-09 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 抗原特異的寛容のための組成物及び方法
EP3461904A1 (en) 2014-11-10 2019-04-03 ModernaTX, Inc. Alternative nucleic acid molecules containing reduced uracil content and uses thereof
US10253045B2 (en) 2014-11-26 2019-04-09 Kala Pharmaceuticals, Inc. Crystalline forms of a therapeutic compound and uses thereof
USD793551S1 (en) 2014-12-03 2017-08-01 Icu Medical, Inc. Fluid manifold
USD786427S1 (en) 2014-12-03 2017-05-09 Icu Medical, Inc. Fluid manifold
WO2016094710A1 (en) 2014-12-10 2016-06-16 Kala Pharmaceuticals, Inc. 1 -amino-triazolo(1,5-a)pyridine-substituted urea derivative and uses thereof
WO2016105528A2 (en) 2014-12-23 2016-06-30 Dana-Farber Cancer Institute, Inc. Inhibitors of cyclin-dependent kinase 7 (cdk7)
CN107206256A (zh) 2014-12-23 2017-09-26 索隆-基特林癌症研究协会 榴菌素b的多形体
US10495645B2 (en) 2015-01-16 2019-12-03 Academia Sinica Cancer markers and methods of use thereof
US9975965B2 (en) 2015-01-16 2018-05-22 Academia Sinica Compositions and methods for treatment and detection of cancers
CA2972072A1 (en) 2015-01-24 2016-07-28 Academia Sinica Novel glycan conjugates and methods of use thereof
JP2018516844A (ja) 2015-03-20 2018-06-28 エルロン・セラピューティクス・インコーポレイテッドAileron Therapeutics,Inc. ペプチド模倣大環状分子およびその使用
US10550121B2 (en) 2015-03-27 2020-02-04 Dana-Farber Cancer Institute, Inc. Inhibitors of cyclin-dependent kinases
KR20230048162A (ko) 2015-03-30 2023-04-10 그린라이트 바이오사이언시스, 아이엔씨. 리보핵산의 무세포 생산
JP6471029B2 (ja) * 2015-04-10 2019-02-13 株式会社ダイセル 注射器
EP3288557A4 (en) 2015-04-27 2018-11-07 University of Florida Research Foundation, Inc. Metabolically programmed metal chelators and uses thereof
WO2016178591A2 (en) 2015-05-05 2016-11-10 Gene Predit, Sa Genetic markers and treatment of male obesity
WO2016201370A1 (en) 2015-06-12 2016-12-15 Dana-Farber Cancer Institute, Inc. Combination therapy of transcription inhibitors and kinase inhibitors
SI3310764T1 (sl) 2015-06-19 2023-06-30 Massachusetts Institute Of Technology Z alkenilom substituirani 2,5-piperazindioni in njihova uporaba v sestavkih za dostavo sredstva subjektu ali celici
WO2017004548A1 (en) 2015-07-01 2017-01-05 Aileron Therapeutics, Inc. Peptidomimetic macrocycles
US10179128B2 (en) 2015-08-31 2019-01-15 Amicus Therapeutics, Inc. Regimens for treating and preventing lysosomal disorders and degenerative disorders of the central nervous system
EP4019515A1 (en) 2015-09-09 2022-06-29 Dana-Farber Cancer Institute, Inc. Inhibitors of cyclin-dependent kinases
US10023613B2 (en) 2015-09-10 2018-07-17 Aileron Therapeutics, Inc. Peptidomimetic macrocycles as modulators of MCL-1
PL3350333T3 (pl) 2015-09-17 2022-03-07 Modernatx, Inc. Polinukleotydy zawierające region stabilizujący ogon
PT3350157T (pt) 2015-09-17 2022-03-18 Modernatx Inc Compostos e composições para administração intracelular de agentes terapêuticos
EP3355882A1 (en) 2015-10-01 2018-08-08 Kythera Biopharmaceuticals, Inc. Compositions comprising a statin for use in methods of adipolysis
GB201518684D0 (en) 2015-10-21 2015-12-02 Glaxosmithkline Biolog Sa Vaccine
WO2017079746A2 (en) 2015-11-07 2017-05-11 Multivir Inc. Methods and compositions comprising tumor suppressor gene therapy and immune checkpoint blockade for the treatment of cancer
AU2016377681B2 (en) 2015-12-22 2021-05-13 Modernatx, Inc. Compounds and compositions for intracellular delivery of agents
JP2019511483A (ja) 2016-03-02 2019-04-25 ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム 免疫療法のためのsting活性化ナノワクチン
JP2019515876A (ja) 2016-03-08 2019-06-13 アカデミア シニカAcademia Sinica N−グリカンおよびそのアレイのモジュール合成のための方法
US10759806B2 (en) 2016-03-17 2020-09-01 Infinity Pharmaceuticals, Inc. Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as PI3K kinase inhibitors
AU2017246458B2 (en) 2016-04-06 2022-08-11 Greenlight Biosciences, Inc. Cell-free production of ribonucleic acid
SG10201913650WA (en) 2016-06-03 2020-03-30 Sanofi Pasteur Inc Modification of engineered influenza hemagglutinin polypeptides
US10105449B2 (en) 2016-06-07 2018-10-23 Massachusetts Institute Of Technology Drug delivery polymers and uses thereof
US10919914B2 (en) 2016-06-08 2021-02-16 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
WO2017218704A1 (en) 2016-06-14 2017-12-21 Modernatx, Inc. Stabilized formulations of lipid nanoparticles
GB201610599D0 (en) 2016-06-17 2016-08-03 Glaxosmithkline Biologicals Sa Immunogenic Composition
NL2017294B1 (en) 2016-08-05 2018-02-14 Univ Erasmus Med Ct Rotterdam Natural cryptic exon removal by pairs of antisense oligonucleotides.
EP3493840B1 (en) 2016-08-05 2022-08-24 Sanofi Pasteur Inc. Multivalent pneumococcal polysaccharide-protein conjugate composition
BR112019001971A2 (pt) 2016-08-05 2019-05-07 Sanofi Pasteur, Inc. composição conjugada de polissacarídeo-proteína pneumocócica multivalente
WO2018035429A1 (en) 2016-08-18 2018-02-22 Wisconsin Alumni Research Foundation Peptides that inhibit syndecan-1 activation of vla-4 and igf-1r
JP7213549B2 (ja) 2016-08-22 2023-01-27 シーエイチオー ファーマ インコーポレイテッド 抗体、結合性断片、および使用の方法
US10030933B2 (en) * 2016-08-25 2018-07-24 Thomas Gore Living Trust Gas spring assembly and a catch therefor
KR101838631B1 (ko) * 2016-11-03 2018-04-26 서울대학교 산학협력단 반복 분사에 따른 젯의 분사 속도 저하를 방지하고 약물의 자동 충전이 가능한 마이크로젯 약물 주입 장치
WO2018089540A1 (en) 2016-11-08 2018-05-17 Modernatx, Inc. Stabilized formulations of lipid nanoparticles
KR101863355B1 (ko) * 2016-12-01 2018-06-01 한국기계연구원 인젝션 량이 가변조절되는 증압식 무침주사기
WO2018106738A1 (en) 2016-12-05 2018-06-14 Massachusetts Institute Of Technology Brush-arm star polymers, conjugates and particles, and uses thereof
WO2018111902A1 (en) 2016-12-12 2018-06-21 Multivir Inc. Methods and compositions comprising viral gene therapy and an immune checkpoint inhibitor for treatment and prevention of cancer and infectious diseases
BR112019013503A2 (pt) 2016-12-31 2020-01-07 Bioxcel Therapeutics, Inc. Uso de dexmedetomidina sublingual para o tratamento da agitação
PL3596041T3 (pl) 2017-03-15 2023-03-06 Modernatx, Inc. Związek i kompozycje do dokomórkowego dostarczania środków terapeutycznych
US11969506B2 (en) 2017-03-15 2024-04-30 Modernatx, Inc. Lipid nanoparticle formulation
WO2018175324A1 (en) 2017-03-20 2018-09-27 The Broad Institute, Inc. Compounds and methods for regulating insulin secretion
SG11201909115WA (en) 2017-04-05 2019-10-30 Broad Inst Inc Tricyclic compounds as glycogen synthase kinase 3 (gsk3) inhibitors and uses thereof
US20200085891A1 (en) 2017-04-21 2020-03-19 Sillajen, Inc Oncolytic vaccinia virus and checkpoint inhibitor combination therapy
US11358926B2 (en) 2017-04-25 2022-06-14 Amicus Therapeutics, Inc. Compositions for preventing and/or treating degenerative disorders of the central nervous system and/or lysosomal storage disorders
US20210198200A1 (en) 2017-06-14 2021-07-01 Modernatx, Inc. Compounds and compositions for intracellular delivery of agents
EP3641828B1 (en) 2017-06-23 2023-11-22 Affinivax, Inc. Immunogenic compositions
WO2019013789A1 (en) 2017-07-12 2019-01-17 Curza Global, Llc ANTIMICROBIAL COMPOUNDS
WO2019013790A1 (en) 2017-07-12 2019-01-17 Curza Global, Llc ANTIMICROBIAL COMPOUNDS AND USES THEREOF
CA3069984A1 (en) 2017-07-27 2019-01-31 Biomerieux, Inc. Isolation tube
WO2019046809A1 (en) 2017-08-31 2019-03-07 Modernatx, Inc. METHODS OF MANUFACTURING LIPID NANOPARTICLES
IL273887B (en) 2017-10-11 2022-09-01 Greenlight Biosciences Inc Methods and preparations for the production of nucleoside triphosphate and ribonucleic acid
EP3717033A4 (en) 2017-12-01 2021-08-25 North Carolina State University FIBRIN PARTICLES AND THEIR PRODUCTION METHODS
WO2019124852A1 (ko) 2017-12-19 2019-06-27 조민수 무침주사기
GB201721576D0 (en) 2017-12-21 2018-02-07 Glaxosmithkline Biologicals Sa Hla antigens and glycoconjugates thereof
GB201721582D0 (en) 2017-12-21 2018-02-07 Glaxosmithkline Biologicals Sa S aureus antigens and immunogenic compositions
WO2019134049A1 (en) 2018-01-05 2019-07-11 Bell John C Modified vaccinia vectors
EP3768698A4 (en) 2018-03-19 2022-03-30 MultiVir Inc. METHODS AND COMPOSITIONS COMPRISING TUMOR SUPPRESSIVE GENE THERAPY AND CD122/CD132 AGONISTS FOR THE TREATMENT OF CANCER
CN114983981A (zh) 2018-06-27 2022-09-02 比奥克斯塞尔医疗股份有限公司 含右美托咪定的膜制剂及其制造方法
JP7410135B2 (ja) 2018-09-19 2024-01-09 モデルナティエックス インコーポレイテッド 治療薬の細胞内送達のための化合物及び組成物
CA3113651A1 (en) 2018-09-20 2020-03-26 Modernatx, Inc. Preparation of lipid nanoparticles and methods of administration thereof
US11160791B2 (en) 2018-11-01 2021-11-02 Medefil, Inc. Dexmedetomidine injection premix formulation in ready to use (RTU) bags
WO2020138476A1 (ja) * 2018-12-27 2020-07-02 株式会社ダイセル 無針注射器
CN113825748A (zh) 2019-01-16 2021-12-21 库扎环球有限责任公司 抗微生物化合物和方法
AU2020209170A1 (en) 2019-01-16 2021-08-12 Curza Global, Llc Antimicrobial compounds and methods
CN111481774B (zh) * 2019-01-25 2023-06-09 凯联医疗科技(上海)有限公司 一种微量药物无针注射器
BR112021014845A2 (pt) 2019-01-31 2021-11-03 Modernatx Inc Métodos de preparação de nanopartículas lipídicas
WO2020168466A1 (en) 2019-02-19 2020-08-27 Stemirna Therapeutics Co., Ltd. Modified nucleoside and synthetic methods thereof
MX2022000709A (es) 2019-07-19 2022-05-19 Bioxcel Therapeutics Inc Regimenes de tratamiento con dexmedetomidina no sedante.
AU2020323498A1 (en) 2019-07-31 2022-03-03 Sk Bioscience Co., Ltd. Multivalent pneumococcal polysaccharide-protein conjugate compositions and methods of using the same
US20220280639A1 (en) 2019-07-31 2022-09-08 Modernatx, Inc. Compositions and methods for delivery of rna interference agents to immune cells
KR102269721B1 (ko) * 2019-08-13 2021-06-28 주식회사 쿼드메디슨 내시경용 마이크로니들 불릿 주입장치
JP2023501575A (ja) 2019-11-13 2023-01-18 カーザ グローバル, エルエルシー 抗菌化合物及び方法
WO2021113644A1 (en) 2019-12-05 2021-06-10 Multivir Inc. Combinations comprising a cd8+ t cell enhancer, an immune checkpoint inhibitor and radiotherapy for targeted and abscopal effects for the treatment of cancer
US11752269B2 (en) * 2019-12-18 2023-09-12 Integrimedical Llc Spring loaded medical needle-free injection system
KR20220133957A (ko) 2020-01-31 2022-10-05 모더나티엑스, 인크. 지질 나노입자의 제조 방법
WO2021173965A1 (en) 2020-02-28 2021-09-02 Massachusetts Institute Of Technology Identification of variable influenza residues and uses thereof
EP4205782A1 (en) * 2020-04-30 2023-07-05 Beijing QS Medical Technology Co., Ltd. Injection head of needleless syringe, needleless syringe body and needleless syringe
WO2021231729A1 (en) 2020-05-13 2021-11-18 Sanofi Adjuvanted stabilized stem hemagglutinin nanoparticles and methods of using the same to induce broadly neutralizing antibodies against influenza
US20230174576A1 (en) 2020-10-30 2023-06-08 Xeno-Interface Inc. Beta-strand bridge peptide
US20230390296A1 (en) 2020-10-30 2023-12-07 Keio University Novel treatment and prevention of sarcopenia-related diseases
AR124267A1 (es) 2020-12-09 2023-03-01 Genentech Inc Métodos de alto rendimiento para preparar nanopartículas lipídicas y sus usos
EP4305088A1 (en) 2021-03-09 2024-01-17 Massachusetts Institute of Technology Branched poly(-amino esters) for the delivery of nucleic acids
TW202313065A (zh) 2021-05-28 2023-04-01 美商季卡尼醫療公司 用於治療遺傳疾病之化合物
CN113318301A (zh) * 2021-06-28 2021-08-31 北京科技大学 一种大剂量多孔无针注射器
WO2023018817A1 (en) 2021-08-11 2023-02-16 Sanofi Pasteur Inc. Truncated influenza neuraminidase and methods of using the same
US20230233667A1 (en) 2021-09-08 2023-07-27 Affinivax, Inc. Coronavirus vaccine
WO2023059857A1 (en) 2021-10-08 2023-04-13 Sanofi Pasteur Inc. Multivalent influenza vaccines
WO2023081798A1 (en) 2021-11-05 2023-05-11 Sanofi Pasteur Inc. Multivalent influenza vaccines comprising recombinant hemagglutinin and neuraminidase and methods of using the same
CA3237139A1 (en) 2021-11-05 2023-05-11 Sanofi Hybrid multivalent influenza vaccines comprising hemagglutinin and neuraminidase and methods of using the same
TW202333654A (zh) 2021-12-16 2023-09-01 美商現代公司 用於製備脂質奈米顆粒之方法
GB2614309A (en) 2021-12-24 2023-07-05 Stratosvir Ltd Improved vaccinia virus vectors
WO2023129963A1 (en) 2021-12-30 2023-07-06 Curza Global, Llc Antimicrobial compounds and methods
WO2023144206A1 (en) 2022-01-27 2023-08-03 Sanofi Pasteur Modified vero cells and methods of using the same for virus production
WO2023144393A1 (en) 2022-01-28 2023-08-03 Fundació Centre De Regulació Genòmica Therapeutic cytokines and methods
US11524105B1 (en) * 2022-03-03 2022-12-13 Hetaida Technology Co., Ltd. Nasal aspirator capable of effectively preventing backflow and control method thereof
WO2023177577A1 (en) 2022-03-14 2023-09-21 Sanofi Pasteur Inc. Machine-learning techniques in protein design for vaccine generation
WO2023193002A1 (en) 2022-04-01 2023-10-05 Modernatx, Inc. Cross mixers for lipid nanoparticle production, and methods of operating the same
WO2023235380A1 (en) 2022-06-01 2023-12-07 Zikani Therapeutics, Inc. Macrolides for treating genetic diseases
CN114870163B (zh) * 2022-06-06 2023-12-19 江苏乐聚医药科技有限公司 气簧混动型无针注射器
WO2023250513A1 (en) 2022-06-24 2023-12-28 Zikani Therapeutics, Inc. 13-membered macrolide compounds for treating diseases mediated by abnormal protein translation
WO2024026482A1 (en) 2022-07-29 2024-02-01 Modernatx, Inc. Lipid nanoparticle compositions comprising surface lipid derivatives and related uses
WO2024026475A1 (en) 2022-07-29 2024-02-01 Modernatx, Inc. Compositions for delivery to hematopoietic stem and progenitor cells (hspcs) and related uses
WO2024026487A1 (en) 2022-07-29 2024-02-01 Modernatx, Inc. Lipid nanoparticle compositions comprising phospholipid derivatives and related uses
WO2024049994A1 (en) 2022-09-01 2024-03-07 Zikani Therapeutics, Inc. Treatment of familial adenomatous polyopsis using a 13-membered macrolide
CN115429974B (zh) * 2022-09-07 2023-09-15 北京快舒尔医疗技术有限公司 无针注射器
WO2024091918A2 (en) 2022-10-25 2024-05-02 Modernatx, Inc. Methods of lipid nanoparticle production in cross-mixers

Family Cites Families (176)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2704543A (en) * 1955-03-22 Hypo jet injector
US3123070A (en) * 1964-03-03 Multidose jet injector
US489727A (en) * 1893-01-10 Suspender-end
US489757A (en) * 1893-01-10 eeilly
US396107A (en) * 1889-01-15 Fluid speed-regulator for elevators
US1567517A (en) * 1924-10-20 1925-12-29 Roy D Kisbey Shock absorber
US1973706A (en) * 1928-11-30 1934-09-18 Hawley Jones Corp Shock absorber
US2322244A (en) * 1940-03-18 1943-06-22 Marshall L Lockhart Hypodermic injector
US2390246A (en) * 1940-10-18 1945-12-04 Marvin L Folkman Syringe
US2322245A (en) * 1943-05-20 1943-06-22 Marshall L Lockhart Ypodermic injector and method of use thereof
US2380534A (en) * 1941-04-26 1945-07-31 Marshall L Lockhart Hypodermic injector
US2413303A (en) * 1944-01-17 1946-12-31 Marvin L Folkman Syringe
US2459875A (en) * 1944-09-11 1949-01-25 Marvin L Folkman Syringe and ampoule
US2398544A (en) * 1945-01-06 1946-04-16 Marshall L Lockhart Hypodermic injector
US2450527A (en) * 1945-10-27 1948-10-05 P & V Quicklocking Co Semiautomatic coupling
US2800903A (en) * 1947-07-30 1957-07-30 Becton Dickinson Co Injection apparatus
US2605763A (en) * 1948-01-31 1952-08-05 Becton Dickinson Co Injection device
US2547099A (en) * 1948-03-11 1951-04-03 Becton Dickinson Co Injection device and ampoule
US2704542A (en) * 1949-02-21 1955-03-22 Scherer Corp R P Jet therapy method
US2688968A (en) * 1949-05-14 1954-09-14 Scherer Corp R P Hypo jet ampoule
US2902994A (en) * 1949-05-21 1959-09-08 Scherer Corp R P Hypo jet injector
US2699166A (en) * 1949-07-29 1955-01-11 Becton Dickinson Co Hypodermic injection unit
US2798485A (en) * 1949-09-01 1957-07-09 Jr George N Hein Ampule
US2737946A (en) * 1949-09-01 1956-03-13 Jr George N Hein Hypodermic injection apparatus
US2653602A (en) * 1950-06-17 1953-09-29 Becton Dickinson Co Injection device
US2754818A (en) * 1950-06-24 1956-07-17 Scherer Corp R P Hypo jet injector
US2671347A (en) * 1950-06-24 1954-03-09 Scherer Corp R P Latch structure
US2681653A (en) * 1950-09-06 1954-06-22 Becton Dickinson Co Hypodermic injection orifice structure and method of making same
US2670121A (en) * 1951-01-31 1954-02-23 Scherer Corp R P Flexible follower for metal ampoules
US2764977A (en) * 1951-05-24 1956-10-02 Becton Dickinson Co Hypodermic injection mechanism
US2635602A (en) * 1951-11-21 1953-04-21 Jr George N Hein Hypodermic injection apparatus
US2821193A (en) * 1952-07-22 1958-01-28 Geoffrey W Walker Multiple injection inoculator instrument
US2789839A (en) * 1952-08-27 1957-04-23 Bissell Carpet Sweeper Co Spring detent engaging means for carpet sweeper sectional handle
US2717597A (en) * 1952-12-04 1955-09-13 Jr George N Hein Injection apparatus
GB766431A (en) * 1953-02-11 1957-01-23 Nat Res Dev Improvements relating to hypodermic injection apparatus
FR1067076A (fr) * 1953-12-16 1954-06-11 Hygiene Scient Hygiscient Lab Perfectionnements aux appareils à injection parentérale sans aiguille
US2820655A (en) * 1953-12-18 1958-01-21 Collins Radio Co Tenacious fastener
US2798486A (en) * 1953-12-21 1957-07-09 Jr George N Hein Injection assembly
US2714887A (en) * 1954-04-26 1955-08-09 Scherer Corp R P Intradermal injector
US2816544A (en) * 1954-07-12 1957-12-17 Scherer Corp R P Hypodermic injector
US2816543A (en) * 1954-07-12 1957-12-17 Scherer Corp R P Hypodermic injector
US2821981A (en) * 1954-07-21 1958-02-04 Geoffrey W Walker Multi-shot inoculant injector instrument with adjustable ejection pressure control
US2825332A (en) * 1954-08-20 1958-03-04 Howard Johnson Electrostatics Hypodermic syringe with magnetically actuated piston and needle
US2762369A (en) * 1954-09-07 1956-09-11 Scherer Corp R P Hypodermic injector with adjustable impact plunger
US2762370A (en) * 1954-09-07 1956-09-11 Scherer Corp R P Hypodermic injector
US3147967A (en) * 1956-06-27 1964-09-08 Bougeard Arthur Pneumatic shock absorber
NL106573C (zh) * 1957-05-31
US2928390A (en) * 1957-07-15 1960-03-15 Scherer Corp R P Multi-dose hypodermic injector
US3057349A (en) 1959-12-14 1962-10-09 Ismach Aaron Multi-dose jet injection device
GB964585A (zh) * 1960-03-23
GB995605A (en) * 1960-08-04 1965-06-23 Amalgamated Dental Co Ltd Improvements relating to hypodermic injection apparatus
NL268186A (zh) * 1960-08-15
FR1072399A (fr) * 1961-01-07 1954-09-13 Injecteur intra-dermique
US3138157A (en) * 1961-05-12 1964-06-23 Z & W Mfg Corp Inoculant injector instrument
US3167071A (en) * 1961-07-17 1965-01-26 Scherer Corp R P Apparatus for administering intradermal injections
US3115133A (en) * 1962-05-15 1963-12-24 Morando Emilio Donald Needleless prefilled disposable hypodermic injector
NL296017A (zh) * 1962-08-03 1900-01-01
BE643768A (zh) * 1963-02-18
US3140713A (en) * 1963-03-25 1964-07-14 Ismach Aaron Intradermal nozzle for jet injection devices
US3202151A (en) * 1963-04-08 1965-08-24 Scherer Corp R P Multidose jet injector
US3330276A (en) * 1963-10-07 1967-07-11 Scherer Corp R P Hypodermic jet injector
US3245703A (en) * 1963-10-28 1966-04-12 Robert S Manly Quick detachable pipe coupling
US3335722A (en) * 1963-11-01 1967-08-15 Olin Mathieson Hypodermic device
US3308818A (en) * 1964-07-24 1967-03-14 Eugene V Rutkowski Injection cartridge
US3330277A (en) * 1964-08-17 1967-07-11 Scherer Corp R P Multidose hypodermic injector
US3292622A (en) * 1964-09-21 1966-12-20 Oscar H Banker Power operated inoculator
US3406684A (en) * 1964-09-28 1968-10-22 Yuryo Kikakuhin Kenkyusho Kk Jet type, medical injection instrument
US3399759A (en) * 1964-11-19 1968-09-03 Express Injector Company Ltd Protecting holders
US3353537A (en) * 1965-08-11 1967-11-21 George W Knox Automatic multi-dosage inoculating instrument
US3424154A (en) * 1965-11-08 1969-01-28 Charles W Kinsley Injection system
US3461867A (en) * 1966-03-14 1969-08-19 Mizzy Inc Needleless injector
US3526225A (en) * 1967-03-31 1970-09-01 Tokyo Sokuhan Kk Jet-type hypodermic injection device
US3527212A (en) * 1967-09-13 1970-09-08 Wesley D Clark Disposable needleless hypodermic injector
US3521633A (en) * 1967-11-13 1970-07-28 Scherer Corp R P Brake device for hypodermic jet injector
US3476110A (en) * 1967-11-13 1969-11-04 Scherer Corp R P Crank for loading hypodermic jet injector
US3490451A (en) * 1967-11-13 1970-01-20 Scherer Corp R P Hypodermic jet injector nozzle
US3518990A (en) * 1968-05-02 1970-07-07 Oscar H Banker Gun type inoculator
US3507276A (en) * 1968-08-28 1970-04-21 Murray B Burgess Jet injector
US3561443A (en) * 1968-09-06 1971-02-09 Oscar H Banker Inoculator gun with delayed action
US3557784A (en) * 1968-12-24 1971-01-26 Walter A Shields Syringe
US3625208A (en) * 1969-05-19 1971-12-07 Mediquip Corp Apparatus for pressure-administering medicaments
US3688765A (en) * 1969-10-03 1972-09-05 Jack S Gasaway Hypodermic injection device
US3659587A (en) * 1970-06-30 1972-05-02 Affiliated Hospital Prod Valved connector arrangement
US3838689A (en) * 1970-11-04 1974-10-01 M Cohen Disposable syringe with slit valve
US3714943A (en) * 1970-12-01 1973-02-06 H Yanof Medicament injectors
US3805783A (en) * 1971-02-12 1974-04-23 A Ismach Hand powered hypodermic jet injector gun
US3783895A (en) * 1971-05-04 1974-01-08 Sherwood Medical Ind Inc Universal parenteral fluid administration connector
US3768472A (en) * 1972-02-07 1973-10-30 M Hodosh Fluid dispensing gun
US3779371A (en) * 1972-03-13 1973-12-18 W Rovinski Package of separated materials to be mixed
DE2254153A1 (de) 1972-11-04 1974-05-09 Werner Dipl Ing Kullmann Selbsttaetiges, universelles injektionsgeraet
US3782380A (en) * 1973-01-04 1974-01-01 Gaast H V D Medicament injecting device
US3827601A (en) * 1973-03-23 1974-08-06 J Magrath Hand powered liquid dispenser of the metering type
US3908651A (en) * 1974-05-17 1975-09-30 Daystrol Scient Inc Medicament injection device
US3938520A (en) * 1974-06-10 1976-02-17 Abbott Laboratories Transfer unit having a dual channel transfer member
US3945379A (en) * 1974-08-08 1976-03-23 Smithkline Corporation Injection device
US3945383A (en) * 1974-08-08 1976-03-23 Smithkline Corporation Unit dose ampul for jet injector
JPS51130094A (en) * 1975-05-08 1976-11-12 Asahi Chemical Ind Twoostage pressure injector
US4141675A (en) * 1975-12-22 1979-02-27 Physics International Company Gas-actuated fuel pump wherein the pump piston is driven by a spring
US4089334A (en) * 1976-10-07 1978-05-16 Schwebel Paul R Pyrotechnically powered needleless injector
DE2817102C2 (de) * 1978-04-19 1985-01-24 Dr. Eduard Fresenius, Chemisch-pharmazeutische Industrie KG, 6380 Bad Homburg Anschlußstück für Kunststoffkanülen oder Venenkatheter
US4328802A (en) * 1980-05-14 1982-05-11 Survival Technology, Inc. Wet dry syringe package
GB2084704B (en) 1980-10-01 1983-06-29 Theobald David Reginald Air rifle
US4373559A (en) * 1980-12-04 1983-02-15 Abbott Laboratories Apparatus for pressurizing an additive transfer device
JPS57103947A (en) * 1980-12-18 1982-06-28 Kuroda Precision Ind Ltd Pneumatic shock absorber
US4421508A (en) * 1981-02-24 1983-12-20 Cohen Edgar C Vacuum-compression injector
US4436519A (en) 1981-05-28 1984-03-13 Argon Medical Corp. Removable hemostasis valve
US4447225A (en) * 1982-03-22 1984-05-08 Taff Barry E Multidose jet injector
CA1178503A (en) 1982-05-27 1984-11-27 Health-Mor Personal Care Corporation Needleless hypodermic injector
US4507113A (en) * 1982-11-22 1985-03-26 Derata Corporation Hypodermic jet injector
US4505709A (en) * 1983-02-22 1985-03-19 Froning Edward C Liquid transfer device
US4518385A (en) * 1983-06-13 1985-05-21 Preci-Tech Ltd. Disposable syringe for needleless injector
HU186718B (en) 1983-06-29 1985-09-30 Radelkis Electrokemiai Automatic needleless syringe operable by cardox cylinder suitable for personal giving injection e.g. insulin
US4561856A (en) 1983-08-18 1985-12-31 Cochran Ulrich D Infusion pump
DE3444817A1 (de) 1984-01-20 1985-07-25 Rasmussen Gmbh, 6457 Maintal Steckkupplung
US4619651A (en) 1984-04-16 1986-10-28 Kopfer Rudolph J Anti-aerosoling drug reconstitution device
US4588403A (en) 1984-06-01 1986-05-13 American Hospital Supply Corporation Vented syringe adapter assembly
US4596556A (en) 1985-03-25 1986-06-24 Bioject, Inc. Hypodermic injection apparatus
GB2173287B (en) 1985-04-01 1988-08-10 Utec Bv Air weapon air compression system
US4675020A (en) 1985-10-09 1987-06-23 Kendall Mcgaw Laboratories, Inc. Connector
US4662878A (en) 1985-11-13 1987-05-05 Patents Unlimited Ltd. Medicine vial adaptor for needleless injector
US4680027A (en) 1985-12-12 1987-07-14 Injet Medical Products, Inc. Needleless hypodermic injection device
US4744786A (en) 1986-06-17 1988-05-17 Cordis Corporation Infusion pump
EP0250022A3 (en) 1986-06-17 1988-06-22 SICIM SpA Portable endermic injector
US4753316A (en) 1986-06-26 1988-06-28 Hydroacoustics Inc. Seismic source
US4722728A (en) 1987-01-23 1988-02-02 Patents Unlimited, Ltd. Needleless hypodermic injector
IT1217047B (it) 1987-03-19 1990-03-14 Cocchi Pietro Siringa per iniezioni,in specie endovenose,realizzata per poteressere usata una sola volta,senza possibilita' di riaspirazione.
USD304616S (en) 1987-04-30 1989-11-14 Derata Corporation Medicament injector
US4941880A (en) 1987-06-19 1990-07-17 Bioject, Inc. Pre-filled ampule and non-invasive hypodermic injection device assembly
US4790824A (en) 1987-06-19 1988-12-13 Bioject, Inc. Non-invasive hypodermic injection device
US4940460A (en) 1987-06-19 1990-07-10 Bioject, Inc. Patient-fillable and non-invasive hypodermic injection device assembly
US4768568A (en) 1987-07-07 1988-09-06 Survival Technology, Inc. Hazardous material vial apparatus providing expansible sealed and filter vented chambers
US4874367A (en) 1988-02-05 1989-10-17 Marpam International, Inc. Hypodermic jet injector and cartridge therefor
US5073165A (en) 1988-02-05 1991-12-17 Marpam International, Inc. Hypodermic jet injector and cartridge therefor
DE3876237T2 (de) 1988-03-25 1993-05-27 Dematex Dev & Trading Inc Proberoehrchen, stopfen und kompressionsring fuer blutprobenentnahmesysteme.
DE8806642U1 (zh) 1988-05-20 1988-09-08 Stabilus Gmbh, 5400 Koblenz, De
DE3818811A1 (de) 1988-06-03 1989-12-14 Stabilus Gmbh Gasfeder mit mehreren hintereinander angeordneten druckraeumen
US5024656A (en) 1988-08-30 1991-06-18 Injet Medical Products, Inc. Gas-pressure-regulated needleless injection system
US4950240A (en) 1988-10-04 1990-08-21 Greenwood Eugene C Hypodermic syringe for single use
JPH02212768A (ja) 1989-02-13 1990-08-23 Terumo Corp 採液管
US5188599A (en) 1989-07-11 1993-02-23 Med-Design, Inc. Retractable needle system
DE3923513A1 (de) 1989-07-15 1991-01-24 Stabilus Gmbh Verfahren und vorrichtung zum einbringen von druckgas in das behaelterrohr einer pneumatischen feder oder dergleichen
CA1325149C (en) 1989-08-31 1993-12-14 Gavin Mcgregor Variable intensity remote controlled needleless injector
AU6550990A (en) 1989-11-09 1991-05-16 Bioject, Inc. Needleless hypodermic injection device
US5312335A (en) 1989-11-09 1994-05-17 Bioject Inc. Needleless hypodermic injection device
US5064413A (en) 1989-11-09 1991-11-12 Bioject, Inc. Needleless hypodermic injection device
US5031266A (en) 1989-12-21 1991-07-16 Whirlpool Corporation Vacuum cleaner wand seal
US4989905A (en) 1990-02-05 1991-02-05 Lamson & Sessions Co. Fitting for corrugated tubing
US5062830A (en) 1990-04-04 1991-11-05 Derata Corporation Dry disposable nozzle assembly for medical jet injector
GB9012829D0 (en) 1990-06-08 1990-08-01 Bernard D J C Reduced diameter dummy piston
GB9017007D0 (en) 1990-08-02 1990-09-19 Bernard Derek J C Improvements to pre-charged pneumatic airguns
GB9020749D0 (en) 1990-09-24 1990-11-07 Bates William T D Improved single-use syringe
DE4038010A1 (de) 1990-11-29 1992-06-04 Stabilus Gmbh Hydraulisch verstellbare lenksaeule
CA2032830C (en) 1990-12-20 1994-07-26 Robert Graham Straghan Coupling
GB9103291D0 (en) 1991-02-15 1991-04-03 Waverley Pharma Ltd Transfer adaptor
US5085332B1 (en) 1991-04-11 1994-04-05 Gettig Technologies Inc Closure assembly
IL98036A0 (en) 1991-05-02 1992-06-21 Yoav Cohen Plastic stand pipe support for load-bearing adjustable piston
GB9118204D0 (en) 1991-08-23 1991-10-09 Weston Terence E Needle-less injector
DE4129271C1 (zh) 1991-09-03 1992-09-17 Fresenius Ag, 6380 Bad Homburg, De
US5356380A (en) 1991-10-23 1994-10-18 Baxter International Inc. Drug delivery system
US5181912A (en) 1991-12-05 1993-01-26 Roy Hammett Non-reusable syringe
US5209362A (en) 1992-01-24 1993-05-11 Lutzker Robert S Can resealer
US5165560A (en) 1992-03-26 1992-11-24 Genesis Industries, Inc. Nonrotating hermetically sealed closure for bottle containing liquid
US5312577A (en) 1992-05-08 1994-05-17 Bioject Inc. Method for manufacturing an ampule
JP2931715B2 (ja) 1992-05-12 1999-08-09 三菱電機株式会社 樹脂封止方法、樹脂封止装置、及びガススプリング
JPH05317383A (ja) 1992-05-19 1993-12-03 Nissho Corp 薬剤容器との連通手段を備えた溶解液容器
US5279576A (en) * 1992-05-26 1994-01-18 George Loo Medication vial adapter
US5383851A (en) 1992-07-24 1995-01-24 Bioject Inc. Needleless hypodermic injection device
USD349958S (en) 1992-07-24 1994-08-23 Bioject Inc. Needleless injector
US5304128A (en) 1992-09-22 1994-04-19 Habley Medical Technology Corporation Gas powered self contained syringe
AU5293393A (en) 1992-09-28 1994-04-26 Equidyne Systems, Incorporated Hypodermic jet injector
US5569189A (en) 1992-09-28 1996-10-29 Equidyne Systems, Inc. hypodermic jet injector
US5334144A (en) 1992-10-30 1994-08-02 Becton, Dickinson And Company Single use disposable needleless injector
US5292308A (en) 1993-05-04 1994-03-08 Ryan Dana W Three piece intravenous line connector
US5344125A (en) 1993-09-17 1994-09-06 Diebolt International, Inc. Gas spring with filler valve
US5352203A (en) 1994-03-31 1994-10-04 Vallelunga Anthony J Aspirating non-reuseable syringe
US5509912A (en) 1994-10-24 1996-04-23 Vlv Associates Connector

Also Published As

Publication number Publication date
EP0802809B1 (en) 2003-04-16
US5891085A (en) 1999-04-06
US5599302A (en) 1997-02-04
JPH10512165A (ja) 1998-11-24
WO1996021482A3 (en) 1996-09-12
WO1996021482A2 (en) 1996-07-18
US5919159A (en) 1999-07-06
AU4693596A (en) 1996-07-31
US5846233A (en) 1998-12-08
ATE237380T1 (de) 2003-05-15
DE69627474D1 (de) 2003-05-22
EP0802809A2 (en) 1997-10-29

Similar Documents

Publication Publication Date Title
TW387814B (en) Device for injecting medical product
CA2259560C (en) Hypodermic jet injector
US6572581B1 (en) Ergonomic needle-less jet injection apparatus and method
US5704911A (en) Needleless hypodermic jet injector
US6096002A (en) NGAS powered self-resetting needle-less hypodermic jet injection apparatus and method
US6752781B2 (en) Durable hypodermic jet injector apparatus and method
US4717384A (en) Pneumatic hypodermic syringe pole
EP2023981B1 (en) Charging mechanism for a needle-free injector
RU2179864C2 (ru) Безыгольный инъектор
EP0712316B1 (en) Reloadable injector
US4874367A (en) Hypodermic jet injector and cartridge therefor
DK2532378T3 (en) needleless injector
RU2131748C1 (ru) Автоматическое или ручное устройство для инъекций жидкого лекарственного средства
JPH07299140A (ja) 使い捨て無針注射器
TW311885B (en) Nozzle assembly with adjustable plunger travel gap
US5073165A (en) Hypodermic jet injector and cartridge therefor
JP2001505069A (ja) 調整可能なプランジャ移動ギャップを備えたノズル組立体
JP2005253995A (ja) 引き込み可能な歯科用シリンジに用いられるカルプル
CA2086486C (en) Drug injection apparatus for an animal
US5389075A (en) Single-use hypodermic syringe
WO1997031664A1 (en) Frangible plunger for nozzle assembly
WO1995016481A1 (en) Medical jet injector for administering injections without a needle
US20220047824A1 (en) Arrangement for aerosol dispenser, aerosol dispenser and method
CN101219252B (zh) 供静脉注射导液管插入用的安全管心针
TWM321300U (en) Medical safety syringe

Legal Events

Date Code Title Description
GD4A Issue of patent certificate for granted invention patent